(All MSCI index returns are shown net and in U.S. dollars unless otherwise noted.)

Markets Review

Sources: CAPS CompositeHubTM, Bloomberg
Past performance is not indicative of future results. Aristotle International Equity Composite returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses. Aristotle Capital Composite returns are preliminary pending final account reconciliation. Please see important disclosures at the end of this document.

Global equity markets rallied in the fourth quarter. Overall, the MSCI ACWI Index rose 11.03% during the period. Concurrently, the Bloomberg Global Aggregate Bond Index increased 8.10%. In terms of style, value stocks underperformed their growth counterparts during the quarter, with the MSCI ACWI Value Index trailing the MSCI ACWI Growth Index by 3.57%.

The MSCI EAFE Index climbed 10.42% during the fourth quarter, while the MSCI ACWI ex USA Index increased 9.75%. Within the MSCI EAFE Index, Europe & Middle East and Asia were the strongest performers, while the U.K., though posting strong absolute results, gained the least. On a sector basis, all eleven sectors within the MSCI EAFE Index posted positive returns, with Information Technology, Materials and Real Estate generating the largest gains. Conversely, Energy, Health Care and Consumer Staples gained the least.

Despite posting overall gains, global equity markets were shocked with another war and humanitarian crisis as tensions between Israel and Hamas reached a watershed during the quarter. In response to the deadly terrorist attack on civilians by Hamas, Israel commenced a military campaign in the Gaza Strip. While concerns that the war might spread throughout the entire Middle East abated during the period, the complex religious, ethnic and political makeup of the region could complicate diplomatic relationships in the future.

Meanwhile, in Europe, Ukraine’s 2023 counteroffensive against Russia was confirmed as a failure, and Western support for the beleaguered nation seems to be waning. President Putin has stated that Russia’s war goals have not changed, but reports indicate that he may be open to a cease-fire. In Asia, President Xi Jinping claimed that reunification is inevitable, adding to the mounting Chinese pressure on Taiwan ahead of Taiwan’s 2024 election.

On the economic front, global labor markets remained tight, and most countries and regions continued to make inroads in the battle against inflation, as the U.S., U.K., eurozone and Japan all reported slowing annual inflation in November; 3.1%, 3.9%, 2.4% and 2.8%, respectively. In response to the improving conditions, both major western and eastern nations largely kept interest rate policy steady during the quarter. However, future policy direction looks to be divided heading into the new year, as the U.S. signaled potential rate cuts, the U.K. and eurozone rebuffed premature discussions of cuts, and Japan looks to end its policy of negative rates in 2024. Nevertheless, the International Monetary Fund expects global inflation to continue to steadily decline due to overall tighter monetary policy and lower commodity prices, which have been further suppressed by the bursting of China’s property bubble.

Annual Markets Review

After a tumultuous year in 2022, global equity markets rebounded in 2023, as the MSCI ACWI posted a full-year return of 22.20%. Additionally, after underperforming value in 2022 by the largest amount since 2000, growth recovered, as the MSCI ACWI Growth Index outperformed the MSCI ACWI Value Index by 21.41% in 2023. Meanwhile, fixed income markets also rose, as the Bloomberg Global Aggregate Bond Index increased 5.72%.

Though markets trended in a positive direction, 2023 still had its share of twists and turns in the form of a banking crisis and geopolitical conflicts in Europe, the Middle East and Asia. Furthermore, inflation, corresponding central bank policies, and economic recovery in areas like Europe and Asia generated significant headlines and proved to be key macroeconomic factors.

Given the multitude of headlines in a year and their fickle nature, short-term returns are often volatile and inconsistent. Therefore, we instead choose to focus on business fundamentals over the long term. By finding great businesses that are undervalued with actionable catalysts within our investment time horizon, we believe we can provide consistent and lasting value to our clients.

Performance and Attribution Summary

For the fourth quarter of 2023, Aristotle Capital’s International Equity ADR Composite posted a total return of 9.53% gross of fees (9.42% net of fees), underperforming the MSCI EAFE Index, which returned 10.42%, and the MSCI ACWI ex USA Index, which returned 9.75%. Please refer to the table below for detailed performance.

Performance (%) 4Q231 Year3 Years5 Years10 Years Since Inception*
International Equity ADR Composite (gross)9.5318.184.208.915.436.17
International Equity ADR Composite (net)9.4217.623.678.414.935.66
MSCI EAFE Index (net)10.4218.244.028.164.285.31
MSCI ACWI ex USA Index (net)9.7515.621.557.083.834.58
*The inception date for the International Equity ADR Composite is June 1, 2013. Past performance is not indicative of future results. Aristotle International Equity ADR Composite returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses. Aristotle Capital Composite returns are preliminary pending final account reconciliation. Please see important disclosures at the end of this document

Source: FactSet
Past performance is not indicative of future results. Attribution results are based on sector returns which are gross of investment advisory fees. Attribution is based on performance that is gross of investment advisory fees and includes the reinvestment of income.

From a sector perspective in the fourth quarter, the portfolio’s underperformance relative to the MSCI EAFE Index can be primarily attributed to allocation effects, while security selection also had a negative impact. Security selection in Industrials and Information Technology and an underweight in Information Technology detracted the most from relative performance. Conversely, security selection in Consumer Discretionary, Financials and Energy contributed to relative return.

Regionally, security selection was responsible for the portfolio’s underperformance, while allocation effects had a slightly positive impact. Security selection in the U.K. and Asia detracted, while exposure to Canada and Emerging Markets contributed.

Contributors and Detractors for 4Q 2023

Relative ContributorsRelative Detractors
BrookfieldRentokil Initial
Assa Abloy Nidec
Experian Haleon
AccentureAlcon
CreditcorpKubota

Rentokil Initial, the U.K.-based pest control and hygiene services company, was the largest detractor for the quarter. The company’s pest control segment (which accounts for 94% of total operating profit) reported a slowdown in organic revenue growth from 5.6% in the first half of 2023 to 2.3% in the third quarter. As these results are short term in nature, we will continue to closely monitor the company’s progress on both integration of Terminix and further improvement of its marketing strategy. This includes the recent appointment of Brad Paulsen as CEO of the North America Region and his impact on the company’s most important geography (accounting for ~75% of pest control sales). Over the long term, we remain confident that the Terminix acquisition will create scale efficiencies and in-market densification (with a targeted $200 million in cost synergies by 2025), as well as accelerate the consolidation of the U.S. pest control market. Short-term impacts on the company’s stock price, in our opinion, are overdone given these fundamental improvements coupled with the resilient nature of the pest control business.

Japan-based Nidec, the global supplier of brushless motors, was one of the largest detractors for the quarter. The company’s electric vehicle (EV) traction motor business has disappointed, with shipment assumptions dropping to 350,000 from 949,000 at the start of the fiscal year. Management also withdrew its ambitious target for the EV business to turn profitable this fiscal year, now projecting an operating loss of ¥15 billion, as it noted all motor suppliers to Chinese EV manufacturers are currently experiencing losses due to intensifying price competition. In response, Nidec has announced a shift in its strategy to both increase R&D spending to accelerate product development and shore up profitability with more selective order placement. While we continue to believe Nidec’s expertise in power efficiency provides it with a unique advantage to supply industrial motors across markets (not only for EVs, but also robots, appliances and industrial applications), we are carefully reviewing whether recent setbacks are cyclical issues or more permanent in nature, and we also continue to monitor changes in leadership, including those set to take place in April 2024.

Door and locks manufacturer Assa Abloy was a leading contributor for the period. Despite a softer residential construction market, the company has shown resiliency as it continues to optimize operating leverage through lower material costs, improved cost structures, price realizations and its strong aftermarket business. As a result, Assa Abloy posted a record adjusted operating margin during the period, which adjusts for the impacts of the 2023 acquisition of Spectrum Brands’ Hardware and Home Improvement. Though the transaction is expected to impact short-term results, management has reported that synergies are already starting to be realized, and we believe that, on a normalized basis, unadjusted operating margins will prove higher than current levels. Moreover, we view this acquisition, along with the other 21 companies acquired in 2023, as demonstrative of the company’s dedication to further investing in its business and cements Assa Abloy’s position as a market leader.

Experian, one of the largest credit bureau companies in the world, was a primary contributor during the quarter. Amidtighter lending conditions, the company continues to show its strength. This includes recent product launches and innovation within the company’s Ascend platform, which leverages deeper analytics so that lenders can automate processes and target audiences more effectively. The credit bureau also expanded its position in employer services and verifications and has seen further digital penetration in areas like Auto and Health. During our well over a decade-long ownership of Experian, the company has increasingly found ways to monetize existing data sets and serve new types of customers. We believe Experian’s unique industry structure and massive data library (with data on ~1.5 billion consumers and ~200 million businesses) not only creates an exceptionally scalable business with high barriers to entry, but also makes it uniquely positioned to benefit from the increased need for big data across many industries.

Recent Portfolio Activity

BuysSells
Daikin IndustriesDassault Systèmes
Sandoz

During the quarter, we sold our positions in Dassault Systèmes and Sandoz and invested in a new position in Daikin Industries.

We first invested in Dassault in the first quarter of 2015. During our more than eight-year holding period, the company executed on a number of catalysts, including a profitable transition to a new software platform (i.e., 3DExperience) and successful entry into new verticals such as life sciences via the 2019 acquisition of Medidata. While we continue to view Dassault as a high-quality company, we decided to exit our investment in favor of what we view as a more optimal opportunity in Daikin Industries, which is discussed in detail below.

We have been Novartis shareholders for over a decade. In October of 2023, the company completed the spinoff of Sandoz, its generics and biosimilars business. This divestiture furthers Novartis’s ongoing transition to a focus on branded prescription drugs, having over the last several years also exited its eye care, vaccine, animal health and consumer healthcare businesses. Upon further analysis, we decided to sell the shares received in the Sandoz spinoff and use the proceeds for what we consider to be a more optimal investment.

Daikin Industries, Ltd.

Founded in 1924 and headquartered in Japan, Daikin Industries is the world’s largest commercial and residential air conditioner company. Daikin primarily manufactures and sells air conditioning systems, heat pumps, air purifiers and refrigeration equipment (which accounts for over 90% of revenue). Daikin has long been an industry leader in developing energy-efficient products, which was molded by its roots in Japan, a region with limited natural resources and high energy costs. The company’s R&D consists of a global Technology Innovation Center and 39 other regional development facilities in charge of tailoring offerings to their local markets. Today Daikin’s products are sold in over 170 countries, and the company boasts leading market positions in Japan and China, as well as in the U.S. residential market.

Distribution is particularly important since air conditioning systems are difficult to install. Daikin’s 2012 acquisition of Goodman in the U.S. added hundreds of distribution points across the country, providing Daikin with a leading national market position and platform from which to expand. In China, specialty retail stores (ProShops) sell directly to homeowners, focusing on high-end, multi-unit products at much higher margins than if they were selling to a developer or contractor.

Some of the quality characteristics we have identified for Daikin include:

  • Strong brand recognition and a large global distribution network are, in our opinion, strong competitive advantages and serve as high barriers to entry;
  • History of technological innovation, particularly in energy-saving inverters and variable refrigerant flow systems; and
  • Ability to tailor products to different local preferences across geographies and varied levels of HVAC regulations, thanks to Daikin’s network of global production bases and development facilities.

Based on our estimates, shares of the company are attractively valued. We believe greater global adoption of air conditioning, as well as higher priced and more profitable technologies (i.e., heat pumps and inverters), will lead to higher normalized FREE cash flow than currently appreciated by the market.

Catalysts we have identified for Daikin, which we believe will cause its stock price to appreciate over our three- to five-year investment horizon, include:

  • As the largest global supplier and a leader in energy efficiency, Daikin is uniquely positioned to benefit from the increase in worldwide air conditioning adoption rates (projected to triple by 2050) while leveraging its intellectual property in inverters and heat pumps;
  • Market share gains in the U.S. as Daikin further leverages its technology in premium residential air conditioning supported by Goodman’s distribution network; and
  • Execution of its Fusion 25 strategic plan that includes making improvements in technological development, strengthening sales and service networks, promoting digital transformation, and more.

Conclusion

With volatile economic data points, changing central bank policies, shocks to the banking system and various geopolitical conflicts, 2023 was full of headline-worthy news. However, as the market’s attention quickly shifted from one macro event to the next, we remained true to our bottom up, fundamental investment philosophy.

As such, instead of chasing the next headline or “placing bets” on short-term predictions, our focus remains on business fundamentals and what is analyzable in the long run. For over the past quarter century, we have dedicated ourselves to a “bottom-up” process of identifying high-quality businesses trading at meaningful discounts to intrinsic value, that possess catalysts which are underway and within management’s control. By doing so, we believe we can find long-term success regardless of the macroeconomic environment or news of the day.

Disclosures

The opinions expressed herein are those of Aristotle Capital Management, LLC (Aristotle Capital) and are subject to change without notice. Past performance is not a guarantee or indicator of future results. This material is not financial advice or an offer to buy or sell any product. You should not assume that any of the securities transactions, sectors or holdings discussed in this report were or will be profitable, or that recommendations Aristotle Capital makes in the future will be profitable or equal the performance of the securities listed in this report. The portfolio characteristics shown relate to the Aristotle International Equity ADR strategy. Not every client’s account will have these characteristics. Aristotle Capital reserves the right to modify its current investment strategies and techniques based on changing market dynamics or client needs. There is no assurance that any securities discussed herein will remain in an account’s portfolio at the time you receive this report or that securities sold have not been repurchased. The securities discussed may not represent an account’s entire portfolio and, in the aggregate, may represent only a small percentage of an account’s portfolio holdings. The performance attribution presented is of a representative account from Aristotle Capital’s International Equity ADR Composite. The representative account is a discretionary client account which was chosen to most closely reflect the investment style of the strategy. The criteria used for representative account selection is based on the account’s period of time under management and its similarity of holdings in relation to the strategy. Recommendations made in the last 12 months are available upon request.

Returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses.

All investments carry a certain degree of risk, including the possible loss of principal. Investments are also subject to political, market, currency and regulatory risks or economic developments. International investments involve special risks that may in particular cause a loss in principal, including currency fluctuation, lower liquidity, different accounting methods and economic and political systems, and higher transaction costs. These risks typically are greater in emerging markets. Securities of small‐ and medium‐sized companies tend to have a shorter history of operations, be more volatile and less liquid. Value stocks can perform differently from the market as a whole and other types of stocks.

The material is provided for informational and/or educational purposes only and is not intended to be and should not be construed as investment, legal or tax advice and/or a legal opinion. Investors should consult their financial and tax adviser before making investments. The opinions referenced are as of the date of publication, may be modified due to changes in the market or economic conditions, and may not necessarily come to pass. Information and data presented has been developed internally and/or obtained from sources believed to be reliable. Aristotle Capital does not guarantee the accuracy, adequacy or completeness of such information.

Aristotle Cpital Management, LLC is an independent registered investment adviser under the Advisers Act of 1940, as amended. Registration does not imply a certain level of skill or training. More information about Aristotle Capital, including our investment strategies, fees and objectives, can be found in our Form ADV Part 2, which is available upon request. ACM-2401-149

Performance Disclosures

Sources: CAPS CompositeHubTM, MSCI

Composite returns for all periods ended December 31, 2023 are preliminary pending final account reconciliation.

Past performance is not indicative of future results. The information provided should not be considered financial advice or a recommendation to purchase or sell any particular security or product.  Performance results for periods greater than one year have been annualized.

Returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses.

Index Disclosures

The MSCI EAFE Index (Europe, Australasia, Far East) is a free float-adjusted market capitalization-weighted index that is designed to measure the equity market performance of developed markets, excluding the United States and Canada. The MSCI EAFE Index consists of the following 21 developed market country indexes: Australia, Austria, Belgium, Denmark, Finland, France, Germany, Hong Kong, Ireland, Israel, Italy, Japan, the Netherlands, New Zealand, Norway, Portugal, Singapore, Spain, Sweden, Switzerland and the United Kingdom. The MSCI ACWI captures large and mid-cap representation across 23 developed market countries and 24 emerging markets countries. With approximately 3,000 constituents, the Index covers approximately 85% of the global investable equity opportunity set. The MSCI ACWI Growth Index captures large and mid-cap securities exhibiting overall growth style characteristics across 23 developed markets countries and 24 emerging markets countries. The MSCI ACWI Value Index captures large and mid-cap securities exhibiting overall value style characteristics across 23 developed markets countries and 24 emerging markets countries. The MSCI ACWI ex USA Index captures large and mid-cap representation across 22 of 23 developed markets countries (excluding the United States) and 24 emerging markets countries. With approximately 2,300 constituents, the Index covers approximately 85% of the global equity opportunity set outside the United States. The MSCI Emerging Markets Index is a free float-adjusted market capitalization-weighted index that is designed to measure the equity market performance of emerging markets. The MSCI Emerging Markets Index consists of the following 24 emerging market country indexes: Brazil, Chile, China, Colombia, Czech Republic, Egypt, Greece, Hungary, India, Indonesia, Korea, Kuwait, Malaysia, Mexico, Peru, Philippines, Poland, Qatar, Saudi Arabia, South Africa, Taiwan, Thailand, Turkey and United Arab Emirates. The S&P 500® Index is the Standard & Poor’s Composite Index of 500 stocks and is a widely recognized, unmanaged index of common stock prices. The Brent Crude Oil Index is a major trading classification of sweet light crude oil that serves as a major benchmark price for purchases of oil worldwide. The MSCI Japan Index is designed to measure the performance of the large and mid-cap segments of the Japanese market. With approximately 250 constituents, the Index covers approximately 85% of the free float-adjusted market capitalization in Japan. The Bloomberg Global Aggregate Bond Index is a flagship measure of global investment grade debt from 28 local currency markets. This multi-currency benchmark includes treasury, government-related, corporate and securitized fixed-rate bonds from both developed and emerging markets issuers. The MSCI United Kingdom Index is designed to measure the performance of the large and mid-cap segments of the U.K. market. With nearly 100 constituents, the Index covers approximately 85% of the free float-adjusted market capitalization in the United Kingdom. The MSCI Europe Index captures large and mid-cap representation across 15 developed markets countries in Europe. With approximately 430 constituents, the Index covers approximately 85% of the free float-adjusted market capitalization across the European developed markets equity universe. These indexes have been selected as the benchmarks and are used for comparison purposes only. The volatility (beta) of the Composite may be greater or less than the respective benchmarks. It is not possible to invest directly in these indexes.

For more on International Equity, access the latest resources.

(All MSCI index returns are shown net and in U.S. dollars unless otherwise noted.)

Markets Review

Sources: CAPS CompositeHubTM, Bloomberg
Past performance is not indicative of future results. Aristotle International Equity Composite returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses. Aristotle Capital Composite returns are preliminary pending final account reconciliation. Please see important disclosures at the end of this document.

After three consecutive positive quarters, global equity markets reversed, as the MSCI ACWI Index fell  3.40% during the period. Concurrently, the Bloomberg Global Aggregate Bond Index decreased 3.59%. In terms of style, value stocks outperformed their growth counterparts during the quarter, with the MSCI ACWI Value Index beating the MSCI ACWI Growth Index by 3.13%.

The MSCI EAFE Index declined  4.11% during the third quarter, while the MSCI ACWI ex USA Index dropped  3.77%. Within the MSCI EAFE Index, Europe & Middle East and Asia were the worst-performing regions, while the U.K. declined the least. On a sector basis, nine out of the eleven sectors within the MSCI EAFE Index posted negative returns, with Information Technology, Utilities and Consumer Discretionary as the worst performers. Conversely, Energy and Financials posted positive returns, while Real Estate declined the least.

Although global financial markets experienced less turmoil than they did earlier this year, inflation remains elevated and economic data remains weak. In fact, the IMF forecast global GDP growth to decline to 3.0% in 2023.

China’s recovery remained sluggish amid an ongoing property slump and lackluster consumer spending. Meanwhile, high levels of inflation persisted across many regions of the world, although inflation in the U.S., eurozone and the U.K. eased significantly from levels seen earlier in the year.  Consistent with the progress, the IMF trimmed its global inflation projection to 6.8% from its prior estimate of 7.0% in April but warned inflation could remain high or reaccelerate due to factors such as geopolitics and weather-related events.

By contrast, in Asia, Japanese inflation edged down to 3.2% in August, and the Bank of Japan diverged from its Western counterparts by keeping short-term interest rates steady. China also took an easier approach to its monetary policy, cutting both short- and medium-term lending rates, as the country has struggled to recover following the pandemic. The People’s Bank of China hopes to combat weak consumer spending, falling exports and the country’s real estate crisis. Chinese property developers have come under increased scrutiny, as Evergrande filed for bankruptcy protection in the U.S. while Country Garden warned investors of significant losses.

On the geopolitical front, Ukraine continues to push its counteroffensive in the eastern and southern portions of the country. Western nations have largely remained dedicated to their support of Ukraine, as countries such as the U.S., Canada and the U.K. have all pledged to provide additional aid. In Taiwan, China carried out military exercises in the Taiwan Strait following the Taiwanese vice president’s visit to New York and San Francisco. Despite tense relations between the U.S. and China, the Biden Administration announced $345 million in military aid for Taiwan.

Performance and Attribution Summary

For the third quarter of 2023, Aristotle Capital’s International Equity ADR Composite posted a total return of -3.79% gross of fees (-3.91% net of fees), outperforming the MSCI EAFE Index, which returned -4.11%, and underperforming the MSCI ACWI ex USA Index, which returned -3.77%. Please refer to the table below for detailed performance.

Performance (%) 3Q23YTD1 Year3 Years5 Years10 Years Since Inception*
International Equity ADR Composite (gross)-3.797.9123.317.194.004.945.39
International Equity ADR Composite (net)-3.917.5022.736.653.534.444.89
MSCI EAFE Index (net)-4.117.0825.655.753.243.824.43
MSCI ACWI ex USA Index (net)-3.775.3420.393.742.583.353.75
*The inception date for the International Equity ADR Composite is June 1, 2013. Past performance is not indicative of future results. Aristotle International Equity ADR Composite returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses. Aristotle Capital Composite returns are preliminary pending final account reconciliation. Please see important disclosures at the end of this document

Source: FactSet

Past performance is not indicative of future results. Attribution results are based on sector returns which are gross of investment advisory fees. Attribution is based on performance that is gross of investment advisory fees and includes the reinvestment of income.

From a sector perspective in the third quarter, the portfolio’s outperformance relative to the MSCI EAFE Index can be attributed to both security selection and allocation effects. Security selection in Consumer Discretionary, Energy and Information Technology contributed the most to the portfolio’s relative performance. Conversely, security selection in Financials, Industrials and Materials detracted from relative return.

Regionally, allocation effects were responsible for the portfolio’s outperformance, while security selection had a negative impact. Exposure to Canada and security selection in Europe & Middle East contributed to relative performance, while security selection in the U.K. and Asia detracted.

Contributors and Detractors for 3Q 2023

Relative ContributorsRelative Detractors
CamecoFANUC
Pan Pacific InternationalDassault Systèmes
TotalEnergiesLVMH
Munich ReinsuranceCredicorp
DBS GroupAshtead Group

Pan Pacific International, the Japanese discount and general merchandise retailer, was a top contributor for the period. After being closed for over two and a half years, Japan’s reopening has led to a sharp recovery in retail traffic. In response, Pan Pacific has implemented an aggressive strategy of increasing the number of cash registers and strengthening staffing to boost sales while also focusing on improving procurement capabilities, expanding its private label strategy and improving its inventory turnover. As a result of these actions, along with favorable weather and a strong holiday season, the company’s sales exceeded pre-pandemic levels, and operating margin eclipsed 5% for the first time in five years. Furthermore, we are encouraged by Pan Pacific’s announcement that it will accelerate the opening of new stores with 25 openings in Japan and 12 stores overseas this year. We believe Pan Pacific is well positioned to continue gaining market share in Japan, further penetrate the overseas market and maintain strong levels of profitability.

TotalEnergies, one of the world’s largest energy companies, was also a primary contributor for the quarter. The company continues to execute on its strategic plan to reach net-zero emissions by 2050 which, in contrast to many European energy providers, it looks to achieve through expanding ownership of renewable power and low-carbon assets rather than purely divestment. The company expects to more than double its gross renewable generation capacity by 2025 (primarily in solar) and invest over 30% of its total spending in low-carbon businesses through 2030. As such, we believe TotalEnergies is uniquely positioned to benefit from the increase in global demand for clean energy. In recent years, TotalEnergies’ reduction in capex and operating expenses has improved its FREE cash flow generation, now further aided by the favorable energy environment. This has supported its continued ability to return cash to shareholders, one of our catalysts, as demonstrated by the $3.8 billion returned through share buybacks and dividends during the second quarter.

Japan-based FANUC, the global manufacturer of industrial robots as well as control systems for machine tools, was the largest detractor for the period. During the June quarter, orders for the company’s robots fell 23% year-on-year following ten consecutive quarters of annual increases. This abrupt decline may have been due to inventory adjustments in China and the Americas as many manufacturers became more cautious over capital investments. Looking past the short-term headwinds, we will continue to monitor the company’s progress shifting its revenue mix toward higher-margin service and IoT capabilities, which should improve profitability. This includes its FIELD platform, which offers predictive maintenance, optimization and self-learning that customers can utilize to reduce production downtime and energy costs. Moreover, we believe long-term prospects for the company are underappreciated since FANUC, as the industrial robot market leader, is uniquely positioned to benefit from further penetration of factory automation and robot usage across geographies.

LVMH Moët Hennessy Louis Vuitton, the luxury goods company, was a primary detractor for the quarter. After doubling sales over the past three years, LVMH is experiencing a slowdown, with organic growth in the recent semi-annual period of only 17%. Regionally, the luxury retail environment is mixed, as strong performance in Asia contrasts with softer demand in the U.S. and a lack of tourist activity from Chinese nationals. Additionally, the company maintained its long-term investment philosophy with increased advertising and promotional spending, which has pressured margins. Despite these near-term challenges, we believe LVMH’s actions will enhance profitability and expand market share in the long run. This includes the company’s continued shift toward Jewelry, which is now the business’s second-largest segment by profit, market share gains in the Selective Retailing segment due to strong performance from Sephora and DFS (Duty Free Shoppers), the successful integration of brands such as Christian Dior Couture, and ongoing integration of Tiffany & Co., which reopened its New York City flagship store “The Landmark” earlier this year.

Recent Portfolio Activity

BuysSells
NoneNone

Consistent with our long-term horizon and low turnover, there were no new purchases or sales completed during the quarter.

Conclusion

Rather than attempting to predict short-term market dynamics, at Aristotle Capital, we stay focused on understanding company fundamentals while carefully monitoring the long-term evolution of our portfolio of holdings. Our approach to understanding individual businesses reveals more insightful conclusions than would undue time spent concentrating on ever-changing and often unclear macroeconomic signals. While we strive to remain macro aware, our goal instead is to invest in businesses which are run by what we believe are capable and proven management teams that have the skill to navigate changing factors such as inflation, interest rates and government policy. We also analyze how such factors could alter the fundamentals of a business and whether those impacts are long term in nature.

We aim to find companies with high-quality characteristics that can succeed over full market cycles. It is our belief that a disciplined, research-oriented approach to finding great companies, as well as a consistent, well-executed portfolio management process, is how we can add the most value for our clients.

Disclosures

The opinions expressed herein are those of Aristotle Capital Management, LLC (Aristotle Capital) and are subject to change without notice. Past performance is not a guarantee or indicator of future results. This material is not financial advice or an offer to buy or sell any product. You should not assume that any of the securities transactions, sectors or holdings discussed in this report were or will be profitable, or that recommendations Aristotle Capital makes in the future will be profitable or equal the performance of the securities listed in this report. The portfolio characteristics shown relate to the Aristotle International Equity ADR strategy. Not every client’s account will have these characteristics. Aristotle Capital reserves the right to modify its current investment strategies and techniques based on changing market dynamics or client needs. There is no assurance that any securities discussed herein will remain in an account’s portfolio at the time you receive this report or that securities sold have not been repurchased. The securities discussed may not represent an account’s entire portfolio and, in the aggregate, may represent only a small percentage of an account’s portfolio holdings. The performance attribution presented is of a representative account from Aristotle Capital’s International Equity ADR Composite. The representative account is a discretionary client account which was chosen to most closely reflect the investment style of the strategy. The criteria used for representative account selection is based on the account’s period of time under management and its similarity of holdings in relation to the strategy. Recommendations made in the last 12 months are available upon request.

Returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses.

All investments carry a certain degree of risk, including the possible loss of principal. Investments are also subject to political, market, currency and regulatory risks or economic developments. International investments involve special risks that may in particular cause a loss in principal, including currency fluctuation, lower liquidity, different accounting methods and economic and political systems, and higher transaction costs. These risks typically are greater in emerging markets. Securities of small‐ and medium‐sized companies tend to have a shorter history of operations, be more volatile and less liquid. Value stocks can perform differently from the market as a whole and other types of stocks.

The material is provided for informational and/or educational purposes only and is not intended to be and should not be construed as investment, legal or tax advice and/or a legal opinion. Investors should consult their financial and tax adviser before making investments. The opinions referenced are as of the date of publication, may be modified due to changes in the market or economic conditions, and may not necessarily come to pass. Information and data presented has been developed internally and/or obtained from sources believed to be reliable. Aristotle Capital does not guarantee the accuracy, adequacy or completeness of such information.

Aristotle Capital Management, LLC is an independent registered investment adviser under the Advisers Act of 1940, as amended. Registration does not imply a certain level of skill or training. More information about Aristotle Capital, including our investment strategies, fees and objectives, can be found in our Form ADV Part 2, which is available upon request. ACM-2310-114

Performance Disclosures

Sources: CAPS CompositeHubTM, MSCI

Composite returns for all periods ended September 30, 2023 are preliminary pending final account reconciliation.

Past performance is not indicative of future results. The information provided should not be considered financial advice or a recommendation to purchase or sell any particular security or product.  Performance results for periods greater than one year have been annualized.

Returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses.

Index Disclosures

The MSCI EAFE Index (Europe, Australasia, Far East) is a free float-adjusted market capitalization-weighted index that is designed to measure the equity market performance of developed markets, excluding the United States and Canada. The MSCI EAFE Index consists of the following 21 developed market country indexes: Australia, Austria, Belgium, Denmark, Finland, France, Germany, Hong Kong, Ireland, Israel, Italy, Japan, the Netherlands, New Zealand, Norway, Portugal, Singapore, Spain, Sweden, Switzerland and the United Kingdom. The MSCI ACWI captures large and mid-cap representation across 23 developed market countries and 24 emerging markets countries. With approximately 3,000 constituents, the Index covers approximately 85% of the global investable equity opportunity set. The MSCI ACWI Growth Index captures large and mid-cap securities exhibiting overall growth style characteristics across 23 developed markets countries and 24 emerging markets countries. The MSCI ACWI Value Index captures large and mid-cap securities exhibiting overall value style characteristics across 23 developed markets countries and 24 emerging markets countries. The MSCI ACWI ex USA Index captures large and mid-cap representation across 22 of 23 developed markets countries (excluding the United States) and 24 emerging markets countries. With approximately 2,300 constituents, the Index covers approximately 85% of the global equity opportunity set outside the United States. The MSCI Emerging Markets Index is a free float-adjusted market capitalization-weighted index that is designed to measure the equity market performance of emerging markets. The MSCI Emerging Markets Index consists of the following 24 emerging market country indexes: Brazil, Chile, China, Colombia, Czech Republic, Egypt, Greece, Hungary, India, Indonesia, Korea, Kuwait, Malaysia, Mexico, Peru, Philippines, Poland, Qatar, Saudi Arabia, South Africa, Taiwan, Thailand, Turkey and United Arab Emirates. The S&P 500® Index is the Standard & Poor’s Composite Index of 500 stocks and is a widely recognized, unmanaged index of common stock prices. The Brent Crude Oil Index is a major trading classification of sweet light crude oil that serves as a major benchmark price for purchases of oil worldwide. The MSCI Japan Index is designed to measure the performance of the large and mid-cap segments of the Japanese market. With approximately 250 constituents, the Index covers approximately 85% of the free float-adjusted market capitalization in Japan. The Bloomberg Global Aggregate Bond Index is a flagship measure of global investment grade debt from 28 local currency markets. This multi-currency benchmark includes treasury, government-related, corporate and securitized fixed-rate bonds from both developed and emerging markets issuers. The MSCI United Kingdom Index is designed to measure the performance of the large and mid-cap segments of the U.K. market. With nearly 100 constituents, the Index covers approximately 85% of the free float-adjusted market capitalization in the United Kingdom. The MSCI Europe Index captures large and mid-cap representation across 15 developed markets countries in Europe. With approximately 430 constituents, the Index covers approximately 85% of the free float-adjusted market capitalization across the European developed markets equity universe. These indexes have been selected as the benchmarks and are used for comparison purposes only. The volatility (beta) of the Composite may be greater or less than the respective benchmarks. It is not possible to invest directly in these indexes.

For more on International Equity, access the latest resources.

ARISTOTLE CAPITAL BOSTON, LLC

Markets Review

The Russell 2000 reversed course after rising over 6% in the month of July, falling -10.6% in August and September, and closing out the quarter with a return of -5.13%. Performance was weaker down the cap spectrum with the Russell 2000 trailing the Russell 1000 for the fourth consecutive quarter, bringing the year-to-date gap between the two indices to 10.47% in favor of large caps. In spite of large caps recent streak of outperformance, many have noted the narrowness of the large cap market rally this year, with a select group of mega cap stocks coined the ‘Magnificent 7’ having driven the vast majority of large cap index gains so far this year. Surging oil prices and treasury yields, a broader and more protracted United Auto Workers strike, and the resumption of student loan payments all contributed to subdued market sentiment into quarter end. On the policy front, even as decades-high inflation showed meaningful signs of slowing, the Fed disappointed some investors’ expectations of a quick pivot to cutting rates. Instead, the central bank indicated its resolve to keep interest rates higher for longer in mid-June, deciding to hold off on raising interest rates as it takes stock of how its prior rate hikes are impacting the real economy.

Stylistically, value stocks proved relatively resilient versus their more expensive growth counterparts during the quarter as evidenced by the Russell 2000 Value Index returning -2.96% compared to -7.32% for the Russell 2000 Growth Index. The gap between the two styles remains wide on a year-to-date basis, however, with the Russell 2000 Growth Index having outperformed its value counterpart by more than 5% so far in 2023.

At the sector level, nine of the eleven sectors in the Russell 2000 Index generated negative returns during the third quarter and only three sectors generated returns ahead of the broader index, representing a second consecutive quarter of narrow sector leadership for the Index. Energy and Financials were the only sectors to deliver gains during the period with returns of 18.62% and 1.21%, respectively. Energy is also the only sector to be up in each of the last two quarters and now leads all sectors on a year-to-date basis after lagging through the first half of the year. Health Care (-15.14%) and Utilities (-11.75%) both ended the quarter with double digit declines and are lagging the Index on a year-to-date basis.

Sources: CAPS Composite Hub, Russell Investments

Past performance is not indicative of future results. Returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses. Aristotle Small Cap Equity Composite returns are preliminary pending final account reconciliation. Please see important disclosures at the end of this document.

Performance Review

For the third quarter of 2023, the Aristotle Small Cap Equity Composite posted a total return of -5.77% net of fees (-5.57% gross of fees), trailing the -5.13% total return of the Russell 2000 Index. Underperformance was driven by a combination of security selection and allocation effects. Overall, security selection was weakest within the Consumer Staples, Financials and Consumer Discretionary sectors and strongest in Health Care, Information Technology and Utilities. From an allocation perspective, the portfolio benefited from underweights in Health Care and Consumer Discretionary, however, this was offset by underweights in Energy and Financials.

Relative ContributorsRelative Detractors
Huron Consulting GroupEuronet Worldwide
MACOM Technology SolutionsDycom
Oceaneering InternationalMerit Medical Systems
HealthEquityMonro
PetIQNu Skin Enterprises

CONTRIBUTORS

Huron Consulting Group (HURN), a specialty consulting company that provides financial, operational, and digital consulting services to health care, education and commercial clients, appreciated after delivering strong results highlighted by continued momentum within the company’s health care and education segments. We maintain our investment, as we believe the company remains well-positioned to capitalize on a demand backdrop aided by financial and operational pressures in its largest end-markets, along with secular tailwinds supporting digital transformation, analytics and cloud consulting.

MACOM Technology Solutions (MTSI), a designer and manufacturer of high-performance semiconductor products, appreciated amid strength within its Industrial and Defense segment along with positive commentary around future AI data center demand. We maintain our position, as we believe the company’s meaningful exposure to growing demand from Data Center and 5G end market applications along with the integration of recent acquisitions should drive additional shareholder value in periods to come.

DETRACTORS

Euronet Worldwide (EEFT), a provider of electronic payment and financial transaction solutions, declined during the period amid inflationary pressures and rising travel costs, leaving consumers with fewer funds for discretionary tourism spending and ultimately resulting in a negative impact on its Electronic Funds Transfer segment. We maintain our investment, as we believe the company’s expansion into mobile and digital payments combined with a continued recovery in international travel can benefit shareholders in the periods to come.

Dycom (DY), a provider of engineering and construction services to the telecommunications and cable television industries, declined amid uncertainty regarding near term customer capital spending initiatives and their ensuing impact on fiber capex plans. We maintain a position as we believe the company remains well positioned for longer term growth alongside secular trends for expanding fiber deployments to support faster broadband connectivity speeds and opportunities to deploy fiber to rural or underserved areas across the country.

Recent Portfolio Activity

Buys/AcquisitionsSells/Liquidations
Patterson-UTI EnergyCalAmp
TKO Group HoldingsNexTier Oilfield Solutions
U.S. Xpress Enterprises
World Wrestling Entertainment

BUYS/ACQUISITIONS

Patterson-UTI Energy (PTEN), an oilfield services company focused on drilling and pressure pumping solutions was added to the portfolio following its merger with NexTier Oilfield Solutions. Overall, we maintain a positive view on the business combination as the merging of the two entities creates a comprehensive drilling and completions franchise with leadership positions in contract drilling, pressure pumping and directional drilling. Furthermore, we believe the company will benefit from greater size and scale, synergistic cost savings initiatives, and a more diversified suite of offerings to serve its customers.

TKO Group Holdings (TKO), a global sports and entertainment company formed through the merger of UFC and WWE, was added to the portfolio during the quarter. With assets spanning media & content, live events, sponsorship and licensing, we believe the company should be able to continue to capitalize on the booming global sports and entertainment ecosystem. Additionally, we believe the company’s diverse global fan base and strategic international expansion plans position the company well amidst favorable industry growth trends and an ever-evolving media rights landscape.

SELLS/LIQUIDATIONS

CalAmp (CAMP), a supplier of Mobile Resource Management solutions that allow for the remote collection of data from vehicles and other assets was removed from the portfolio during the quarter. In spite of the company’s efforts to convert its customer base from a hardware to a subscription model, redesign its customer support systems, and introduce new products in recent years, a variety of factors contributed to the harvesting of these efforts being pushed out, unfavorably impacting the risk-reward profile of the business. Therefore, we decided to eliminate the position.

NexTier Oilfield Solutions (NEX), a provider of hydraulic fracturing and other completion-oriented oilfield services to exploration and production companies in the U.S. was removed from the portfolio by virtue of its merger with Patterson-UTI Energy.

U.S. Xpress Enterprises (USX), a Tennessee-based trucking company was removed from the portfolio after being acquired by Knight-Swift Transportation.

World Wrestling Entertainment (WWE), an integrated media and entertainment company, was removed from the portfolio following its merger with Endeavor Group-owned UFC. The new publicly listed company that will combine the two entities will operate under the name TKO Group Holdings.

Outlook

Outside of a few major surprises, including the regional banking situation and an overly optimistic period of AI euphoria, it is perhaps surprising how little market risks and narratives have shifted over the last nine months. The two big uncertainties that many investors highlighted at the start of the year (i) whether inflation would persist and, (ii) whether there would be a recession, remain largely unresolved. While it is clear in the hard data that inflation has dropped over the course of the year, recent readings remain uncomfortably above the Federal Reserve’s target levels. Rapid increases in food and energy prices also persisted throughout the quarter fueling further uncertainty in the outlook. On the economy, the consensus view at the start of 2023 was that we were heading into a recession, with the only questions being when it would kick in, and how deep it would be. To this point, those questions still remain. One reason for market resiliency this year has been the performance of the economy, which has managed to not only avoid a recession to this point but also deliver strong employment numbers. Against this uncertain backdrop, the market may continue swinging between wild optimism, where inflation is no longer viewed as a threat and the economy has a soft landing, and extreme pessimism, where inflation comes roaring back, and the economy falls into a recession. Because of the difficulty in forecasting these macroeconomic outcomes, we have always strived to avoid making such predictions. Instead, we will – as always – stay focused on forecasting the underlying fundamentals of the companies in which we invest rather than making top-down investment or portfolio decisions. We do, however, believe that a normalization of financial conditions through higher rates (nominal and real) and QT should result in a more favorable market environment for quality companies with strong fundamentals better than it had been in the years leading up to, and through the pandemic/2021 period during which “Easy Money Policy” distorted market and style dynamics. Thus far in 2023, including the third quarter, we have seen short-term periods where more reasonably valued companies have recovered on a relative basis, but this has not been a linear shift in the market as much of the first half rally was more sentiment-driven than fundamentally supported, in our view. Ultimately, we believe business fundamentals and valuations are the key determinants of investment returns over extended periods and that remains our focus.

From an asset class perspective, valuations of small versus large continue to remain near multi-decade lows, which we believe suggests a more favorable setup for small caps relative to large caps in the periods to come (12.3x P/E for the Russell 2000 Index vs. 21.2x P/E for the Russell 1000 Index). Based upon relative P/E alone, there has been no other time in the Russell 2000’s history that has been as attractive relative to large cap as in recent times. Additionally, earnings and sales growth are expected to improve for small caps in 2024 and outpace that of large caps, which we believe provides further fundamental support and potential upside for the asset class. A peak in US large cap market concentration has also historically been followed by sustained small cap outperformance. Small caps are less vulnerable to a top-heavy market, helping reduce the index’s sensitivity to individual company performance. Moreover, small caps tend to outperform large caps when inflation falls from high levels as well as during recovery periods coming out of economic downturns. Investors thinking of positioning around these trends may benefit from moving down in market capitalization, in our opinion.

Positioning

As always, we remain focused on long-term business fundamentals, even in the face of elevated short-term volatility. Our current positioning is a function of our bottom-up security selection process and our ability to identify what we view as attractive investment candidates, regardless of economic sector definitions. Overweights in Industrials and Information Technology are mostly a function of recent portfolio activity and the relative performance of our holdings in these sectors over the past few periods. Conversely, we continue to be underweight in Consumer Discretionary, as we have been unable to identify what we consider to be compelling long-term opportunities that fit our discipline given the rising risk profiles of many retail businesses and a potential deceleration in goods spending following a period of strength fueled in part by government backed stimulus payments. While the portfolio’s allocation to Health Care is modestly below that of the benchmark’s, we continue to remain underweight the Biotechnology industry as many companies within that group do not fit our discipline due to their elevated levels of binary risk. Given the rising levels of volatility and the apparent short-term disconnect between certain areas of the market and business fundamentals, we believe it is important to remain patient in identifying investment opportunities to ensure they offer a compelling risk-reward trade-off and a sufficient margin of safety. Furthermore, we remain focused on trying to understand the risks associated with each investment position within the context of our fundamentally oriented research process and managing those risks through a disciplined approach to portfolio construction and management.

Disclosures

The opinions expressed herein are those of Aristotle Capital Boston, LLC (Aristotle Boston) and are subject to change without notice.

Past performance is not indicative of future results. The information provided in this report should not be considered financial advice or a recommendation to purchase or sell any particular security. There is no assurance that any securities discussed herein will remain in an account’s portfolio at the time you receive this report or that securities sold have not been repurchased. The securities discussed may not represent an account’s entire portfolio and, in the aggregate, may represent only a small percentage of an account’s portfolio holdings. The performance attribution presented is of a representative account from Aristotle Boston’s Small Cap Equity Composite. The representative account is a discretionary client account which was chosen to most closely reflect the investment style of the strategy. The criteria used for representative account selection is based on the account’s period of time under management and its similarity of holdings in relation to the strategy. It should not be assumed that any of the securities transactions, holdings or sectors discussed were or will be profitable, or that the investment recommendations or decisions Aristotle Boston makes in the future will be profitable or equal the performance of the securities discussed herein. Aristotle Boston reserves the right to modify its current investment strategies and techniques based on changing market dynamics or client needs. Recommendations made in the last 12 months are available upon request.

Returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses.

Effective January 1, 2022, the Aristotle Small Cap Equity Composite has been redefined to exclude accounts with meaningful industry-specific restrictions or substantial values-based screens hampering implementation of the small cap strategy.

Effective January 1, 2022, the Russell 2000 Value Index was removed as the secondary benchmark for the Aristotle Capital Boston Small Cap Equity strategy.

All investments carry a certain degree of risk, including the possible loss of principal. Investments are also subject to political, market, currency and regulatory risks or economic developments. International investments involve special risks that may in particular cause a loss in principal, including currency fluctuation, lower liquidity, different accounting methods and economic and political systems, and higher transaction costs.

These risks typically are greater in emerging markets. Securities of small‐ and medium‐sized companies tend to have a shorter history of operations, be more volatile and less liquid. Value stocks can perform differently from the market as a whole and other types of stocks. The material is provided for informational and/or educational purposes only and is not intended to be and should not be construed as investment, legal or tax advice and/or a legal opinion. Investors should consult their financial and tax adviser before making investments.

The opinions referenced are as of the date of publication, may be modified due to changes in the market or economic conditions, and may not necessarily come to pass.

The firm’s coverage of Signature Bank includes time at a predecessor firm.

Aristotle Capital Boston, LLC is an independent investment adviser registered under the Investment Advisers Act of 1940, as amended. Registration does not imply a certain level of skill or training. More information about Aristotle Boston, including our investment strategies, fees and objectives, can be found in our Form ADV Part 2, which is available upon request. ACB-2310-17

Performance Disclosures

Sources: CAPS Composite Hub, Russell Investments

Composite returns for periods ended September 30, 2023 are preliminary pending final account reconciliation.

*The Aristotle Small Cap Equity Composite has an inception date of November 1, 2006 at a predecessor firm. During this time, Jack McPherson and Dave Adams had primary responsibility for managing the strategy. Performance starting January 1, 2015 was achieved at Aristotle Boston.

**For the period November 2006 through December 2006.

Past performance is not indicative of future results. Performance results for periods greater than one year have been annualized.

Effective January 1, 2022, the Aristotle Small Cap Equity Composite has been redefined to exclude accounts with meaningful industry-specific restrictions or substantial values-based screens hampering implementation of the small cap strategy.

Effective January 1, 2022, the Russell 2000 Value was removed as the secondary benchmark for the Aristotle Capital Boston Small Cap Equity strategy.

Returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses. Please see important disclosures enclosed within this document.

Index Disclosures

The Russell 2000® Index measures the performance of the small cap segment of the U.S. equity universe. The Russell 2000 Index is a subset of the Russell 3000® Index representing approximately 10% of the total market capitalization of that index. It includes approximately 2000 of the smallest securities based on a combination of their market cap and current index membership. The Russell 2000 Growth® Index measures the performance of the small cap companies located in the United States that also exhibit a growth probability. The Russell 2000 Value® Index measures the performance of the small cap companies located in the United States that also exhibit a value probability. The Russell 1000® Index measures the performance of the large cap segment of the U.S. equity universe. The Russell 1000 Index is a subset of the Russell 3000® Index, representing approximately 90% of the total market capitalization of that index. It includes approximately 1,000 of the largest securities based on a combination of their market capitalization and current index membership. The volatility (beta) of the composite may be greater or less than the benchmarks. It is not possible to invest directly in these indices.

For more on Small Cap Equity, access the latest resources.

ARISTOTLE CAPITAL BOSTON, LLC

Markets Review

The Russell 2500 reversed course after rising 4.97% in the month of July, falling -9.29% in August and September, and closing out the quarter with a return of -4.78%. Performance was weaker down the cap spectrum with the Russell 2500 trailing the Russell 1000 for the third consecutive quarter, bringing the year-to-date gap between the two indices to 9.42% in favor of large caps. In spite of large caps recent streak of outperformance, many have noted the narrowness of the large cap market rally this year, with a select group of mega cap stocks coined the ‘Magnificent 7’ having driven the vast majority of large cap index gains so far this year. Surging oil prices and treasury yields, a broader and more protracted United Auto Workers strike, and the resumption of student loan payments all contributed to  subdued market sentiment into quarter end. On the policy front, even as decades-high inflation showed meaningful signs of slowing, the Fed disappointed some investors’ expectations of a quick pivot to cutting rates. Instead, the central bank indicated its resolve to keep interest rates higher for longer in mid-June, deciding to hold off on raising interest rates as it takes stock of how its prior rate hikes are impacting the real economy.

Stylistically, value stocks proved relatively resilient versus their more expensive growth counterparts during the quarter as evidenced by the Russell 2500 Value Index returning -3.66% compared to –6.84% for the Russell 2500 Growth Index. The gap between the two styles remains elevated on a year-to-date basis, however, with the Russell 2500 Growth Index having outperformed its value counterpart by 3.68% so far in 2023.

At the sector level, nine of the eleven sectors in the Russell 2500 Index generated negative returns during the third quarter and only four sectors generated returns ahead of the broader index, representing a second consecutive quarter of narrow sector leadership for the Index. Energy and Financials were the only sectors to deliver positive returns during the period with returns of 17.18% and 1.31%, respectively. Health Care (-14.22%) and Communication Services (-11.18%) both ended the quarter with double digit declines and are lagging the Index on a year-to-date basis.

Sources: CAPS Composite Hub, Russell Investments

Past performance is not indicative of future results. Returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses. Aristotle Small Cap Equity Composite returns are preliminary pending final account reconciliation. Please see important disclosures at the end of this document.

Performance Review

For the third quarter of 2023, the Aristotle Small/Mid Cap Equity Composite generated a total return of -3.54% net of fees (-3.40% gross of fees), outperforming the -4.78% total return of the Russell 2500 Index. Outperformance was driven by a combination of security selection and allocation effects. Overall, security selection was strongest within the Health Care, Information Technology, and Industrials sectors and weakest in Financials, Consumer Discretionary and Consumer Staples. From an allocation perspective, underweights in Consumer Discretionary and Real Estate contributed to relative returns but were modestly offset by an overweight in Health Care and an underweight in Financials.

Relative ContributorsRelative Detractors
MACOM Technology SolutionsDycom
Huron Consulting GroupEuronet Worldwide
OceaneeringWolverine World Wide
Diamondback EnergyMerit Medical Systems
Range ResourcesMonro

CONTRIBUTORS

MACOM Technology Solutions (MTSI), a designer and manufacturer of high-performance semiconductor products, appreciated amid strength within its Industrial and Defense segment along with positive commentary around future AI data center demand.  We maintain our position, as we believe the company’s meaningful exposure to growing demand from Data Center and 5G end market applications along with the integration of recent acquisitions should drive additional shareholder value in periods to come.

Huron Consulting Group (HURN), a specialty consulting company that provides financial, operational, and digital consulting services to health care, education and commercial clients, appreciated after delivering strong results highlighted by continued momentum within the company’s health care and education segments. We maintain our investment, as we believe the company remains well-positioned to capitalize on a demand backdrop aided by financial and operational pressures in its largest end-markets, along with secular tailwinds supporting digital transformation, analytics and cloud consulting.

DETRACTORS

Dycom (DY), a provider of engineering and construction services to the telecommunications and cable television industries, declined amid uncertainty regarding near term customer capital spending initiatives and their ensuing impact on fiber capex plans. We maintain a position as we believe the company remains well positioned for longer term growth alongside secular trends for expanding fiber deployments to support faster broadband connectivity speeds and opportunities to deploy fiber to rural or underserved areas across the country.

Euronet Worldwide (EEFT), a provider of electronic payment and financial transaction solutions, declined during the period amid inflationary pressures and rising travel costs, leaving consumers with fewer funds for discretionary tourism spending and ultimately resulting in a negative impact on its Electronic Funds Transfer segment. We maintain our investment, as we believe the company’s expansion into mobile and digital payments combined with a continued recovery in international travel can benefit shareholders in the periods to come.

Recent Portfolio Activity

Buys/AcquisitionsSells/Liquidations
Patterson-UTI EnergyCalAmp
TKO Group HoldingsNexTier Oilfield Solutions
World Wrestling Entertainment

BUYS/ACQUISITIONS

Patterson-UTI Energy (PTEN), an oilfield services company focused on drilling and pressure pumping solutions was added to the portfolio following its merger with NexTier Oilfield Solutions. Overall, we maintain a positive view on the business combination as the merging of the two entities creates a comprehensive drilling and completions franchise with leadership positions in contract drilling, pressure pumping and directional drilling. Furthermore, we believe the company will benefit from greater size and scale, synergistic cost savings initiatives, and a more diversified suite of offerings to serve its customers.

TKO Group Holdings (TKO), a global sports and entertainment company formed through the merger of UFC and WWE, was added to the portfolio during the quarter. With assets spanning media & content, live events, sponsorship and licensing, we believe the company should be able to continue to capitalize on the booming global sports and entertainment ecosystem. Additionally, we believe the company’s diverse global fan base and strategic international expansion plans position the company well amidst favorable industry growth trends and an ever-evolving media rights landscape.

SELLS/LIQUIDATIONS

CalAmp (CAMP), a supplier of Mobile Resource Management solutions that allow for the remote collection of data from vehicles and other assets was removed from the portfolio during the quarter. In spite of the company’s efforts to convert its customer base from a hardware to subscription model, redesign its customer support systems, and introduce new products in recent years, a variety of factors contributed to the harvesting of these efforts being pushed out, unfavorably impacting the risk-reward profile of the business. Therefore, we decided to eliminate the position.

NexTier Oilfield Solutions (NEX), a provider of hydraulic fracturing and other completion-oriented oilfield services to exploration and production companies in the U.S. was removed from the portfolio by virtue of its merger with Patterson-UTI Energy.

World Wrestling Entertainment (WWE), an integrated media and entertainment company, was removed from the portfolio following its merger with Endeavor Group-owned UFC. The new publicly listed company that will combine the two entities will operate under the name TKO Group Holdings.

Outlook

Outside of a few major surprises, including the regional banking situation and an overly optimistic period of AI euphoria, it is perhaps surprising how little market risks and narratives have shifted over the last nine months. The two big uncertainties that many investors highlighted at the start of the year (i) whether inflation would persist and, (ii) whether there would be a recession, remain largely unresolved. While it is clear in the hard data that inflation has dropped over the course of the year, recent readings remain uncomfortably above the Federal Reserve’s target levels. Rapid increases in food and energy prices also persisted throughout the quarter fueling further uncertainty in the outlook. On the economy, the consensus view at the start of 2023 was that we were heading into a recession, with the only questions being when it would kick in, and how deep it would be. To this point, those questions still remain. One reason for market resiliency this year has been the performance of the economy, which has managed to not only avoid a recession to this point but also deliver strong employment numbers. Against this uncertain backdrop, the market may continue swinging between wild optimism, where inflation is no longer viewed as a threat and the economy has a soft landing, and extreme pessimism, where inflation comes roaring back, and the economy falls into a recession. Because of the difficulty in forecasting these macroeconomic outcomes, we have always strived to avoid making such predictions. Instead, we will – as always – stay focused on forecasting the underlying fundamentals of the companies in which we invest rather than making top-down investment or portfolio decisions. We do, however, believe that a normalization of financial conditions through higher rates (nominal and real) and QT should result in a more favorable market environment for quality companies with strong fundamentals better than it had been in the years leading up to, and through the pandemic/2021 period during which “Easy Money Policy” distorted market and style dynamics. Thus far in 2023, including the third quarter, we have seen short-term periods where more reasonably valued companies have recovered on a relative basis, but this has not been a linear shift in the market as much of the first half rally was more sentiment-driven than fundamentally supported, in our view. Ultimately, we believe business fundamentals and valuations are the key determinants of investment returns over extended periods and that remains our focus.

From an asset class perspective, valuations of small versus large continue to remain near multi-decade lows, which we believe suggests a more favorable setup for small caps relative to large caps in the periods to come (13.2x P/E for the Russell 2500 Index vs. 21.2x P/E for the Russell 1000 Index). Based upon relative P/E alone, there has been no other time in the Russell 2500’s history that has been as attractive relative to large cap as in recent times. Additionally, earnings and sales growth are expected to improve for small & mid caps in 2024 and outpace that of large caps, which we believe provides further fundamental support and potential upside for the asset class. A peak in US large-cap market concentration has also historically been followed by sustained small & mid cap outperformance. Small & mid caps are less vulnerable to a top-heavy market, helping reduce the index’s sensitivity to individual company performance. Moreover, small & mid caps tend to outperform large caps when inflation falls from high levels as well as during recovery periods coming out of economic downturns. Investors thinking of positioning around these trends may benefit from moving down in market capitalization, in our opinion.

Positioning

As always, we remain focused on long-term business fundamentals, even in the face of elevated short-term volatility. Our current positioning is a function of our bottom-up security selection process and our ability to identify what we view as attractive investment candidates, regardless of economic sector definitions. Overweights in Industrials and Information Technology are mostly a function of recent portfolio activity and the relative performance of our holdings in these sectors over the past few periods. Conversely, we continue to be underweight in Consumer Discretionary, as we have been unable to identify what we consider to be compelling long-term opportunities that fit our discipline given the rising risk profiles of many retail businesses and a potential deceleration in goods spending following a period of strength fueled in part by government backed stimulus payments. We also continue to be underweight in Real Estate as a result of structural challenges for various end markets within the sector. Given our focus on long-term business fundamentals, patient investment approach and low portfolio turnover, the strategy’s sector positioning generally does not change significantly from quarter to quarter. However, we may take advantage of periods of volatility by adding selectively to certain companies when appropriate.

Disclosures

The opinions expressed herein are those of Aristotle Capital Boston, LLC (Aristotle Boston) and are subject to change without notice.

Past performance is not indicative of future results. The information provided in this report should not be considered financial advice or a recommendation to purchase or sell any particular security. There is no assurance that any securities discussed herein will remain in an account’s portfolio at the time you receive this report or that securities sold have not been repurchased. The securities discussed may not represent an account’s entire portfolio and, in the aggregate, may represent only a small percentage of an account’s portfolio holdings. The performance attribution presented is of a representative account from Aristotle Boston’s Small/Mid Cap Equity Composite. The representative account is a discretionary client account which was chosen to most closely reflect the investment style of the strategy. The criteria used for representative account selection is based on the account’s period of time under management and its similarity of holdings in relation to the strategy. It should not be assumed that any of the securities transactions, holdings or sectors discussed were or will be profitable, or that the investment recommendations or decisions Aristotle Boston makes in the future will be profitable or equal the performance of the securities discussed herein. Aristotle Boston reserves the right to modify its current investment strategies and techniques based on changing market dynamics or client needs. Recommendations made in the last 12 months are available upon request.

Returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses.

Effective January 1, 2022, the Russell 2500 Value Index was removed as the secondary benchmark for the Aristotle Boston Small/Mid Cap Equity strategy.

Non-fee-paying accounts represented less than 5% of the SMID Cap Composite assets from December 31, 2010 to December 31, 2013. As of December 31, 2014, there were no non-fee-paying accounts in the Composite. In instances where non-fee paying accounts were included in the SMID Cap Composite, the highest model fee was applied to recalculate the net returns for composite purposes and the impact on the since inception return of the composite was deemed immaterial.

All investments carry a certain degree of risk, including the possible loss of principal. Investments are also subject to political, market, currency and regulatory risks or economic developments. International investments involve special risks that may in particular cause a loss in principal, including currency fluctuation, lower liquidity, different accounting methods and economic and political systems, and higher transaction costs.

These risks typically are greater in emerging markets. Securities of small‐ and medium‐sized companies tend to have a shorter history of operations, be more volatile and less liquid. Value stocks can perform differently from the market as a whole and other types of stocks.

The material is provided for informational and/or educational purposes only and is not intended to be and should not be construed as investment, legal or tax advice and/or a legal opinion. Investors should consult their financial and tax adviser before making investments.

The opinions referenced are as of the date of publication, may be modified due to changes in the market or economic conditions, and may not necessarily come to pass.

The firm’s coverage of Signature Bank includes time at a predecessor firm.

Aristotle Capital Boston, LLC is an independent investment adviser registered under the Investment Advisers Act of 1940, as amended. Registration does not imply a certain level of skill or training. More information about Aristotle Boston, including our investment strategies, fees and objectives, can be found in our Form ADV Part 2, which is available upon request. ACB-2310-18

Performance Disclosures

Sources: CAPS Composite Hub, Russell Investments

Composite returns for periods ended September 30, 2023 are preliminary pending final account reconciliation.

*The Aristotle Small/Mid Cap Equity Composite has an inception date of January 1, 2008 at a predecessor firm. During this time, Jack McPherson and Dave Adams had primary responsibility for managing the strategy. Performance starting January 1, 2015 was achieved at Aristotle Boston.

Effective January 1, 2022, the Russell 2500 Value Index was removed as the secondary benchmark for the Aristotle Boston Small/Mid Cap Equity Strategy.  Non-fee-paying accounts represented less than 5% of the SMID Cap Composite assets from December 31, 2010 to December 31, 2013. As of December 31, 2014, there were no non-fee-paying accounts in the Composite. In instances where non-fee paying accounts were included in the SMID Cap Composite, the highest model fee was applied to recalculate the net returns for composite purposes and the impact on the since inception return of the composite was deemed immaterial. Past performance is not indicative of future results. Performance results for periods greater than one year have been annualized.

Returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses. Please see important disclosures enclosed within this document.

Index Disclosures

The Russell 2500 Index is a subset of the Russell 3000® Index representing approximately 10% of the total market capitalization of that index. It includes approximately 2000 of the smallest securities based on a combination of their market cap and current index membership. The Russell 2500 Growth® Index measures the performance of the small/mid cap companies located in the United States that also exhibit a growth probability. The Russell 2500 Value® Index measures the performance of the small/mid cap companies located in the United States that also exhibit a value probability. The Russell 1000 Index is a subset of the Russell 3000® Index, representing approximately 90% of the total market capitalization of that index. It includes approximately 1,000 of the largest securities based on a combination of their market capitalization and current index membership. The volatility (beta) of the composite may be greater or less than the benchmarks. It is not possible to invest directly in these indices.

For more on Small Cap Equity, access the latest resources.

(All MSCI index returns are shown net and in U.S. dollars unless otherwise noted.)

Markets Review

Sources: CAPS CompositeHubTM, Bloomberg
Past performance is not indicative of future results. Aristotle International Equity Composite returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses. Aristotle Capital Composite returns are preliminary pending final account reconciliation. Please see important disclosures at the end of this document.

After three consecutive positive quarters, global equity markets reversed, as the MSCI ACWI Index fell 3.40% during the period. Concurrently, the Bloomberg Global Aggregate Bond Index decreased 3.59%. In terms of style, value stocks outperformed their growth counterparts during the quarter, with the MSCI ACWI Value Index beating the MSCI ACWI Growth Index by 3.13%.

Both regionally and on a sector basis, declines were broad-based. Asia/Pacific ex-Japan and Europe were the worst performers, while Latin America, the only region to post a positive return, and Japan were the best. Meanwhile, nine out of the eleven sectors within the MSCI ACWI Index posted losses, with Utilities, Real Estate and Consumer Staples being the worst performers. Energy and Communication Services finished in the green, while Financials declined the least.

Although global financial markets experienced less turmoil than they did earlier this year, inflation remains elevated and economic data remains weak. In fact, the IMF forecast global GDP growth to decline to 3.0% in 2023.

China’s recovery remained sluggish amid an ongoing property slump and lackluster consumer spending. Meanwhile, high levels of inflation persisted across many regions of the world, although inflation in the U.S., eurozone and the U.K. eased significantly from levels seen earlier in the year. As such, the IMF trimmed its global inflation projection to 6.8% from its prior estimate of 7.0% in April but warned inflation could remain high or reaccelerate due to factors such as geopolitics and weather-related events.

By contrast, in Asia, Japanese inflation edged down to 3.2% in August, and the Bank of Japan diverged from its Western counterparts by keeping short-term interest rates steady. China also took an easier approach to its monetary policy, cutting both short- and medium-term lending rates, as the country has struggled to recover following the pandemic. The People’s Bank of China hopes to combat weak consumer spending, falling exports and the country’s real estate crisis. Chinese property developers have come under increased scrutiny, as Evergrande filed for bankruptcy protection in the U.S. while Country Garden warned investors of significant losses.

On the geopolitical front, Ukraine continues to push its counteroffensive in the eastern and southern portions of the country. Western nations have largely remained dedicated to their support of Ukraine, as countries such as the U.S., Canada and the U.K. have all pledged to provide additional aid. In Taiwan, China carried out military exercises in the Taiwan Strait following the Taiwanese vice president’s visit to New York and San Francisco. Despite tense relations between the U.S. and China, the Biden Administration announced $345 million in military aid for Taiwan.

Performance and Attribution Summary

For the third quarter of 2023, Aristotle Capital’s Global Equity Composite posted a total return of -4.06% gross of fees (-4.13% net of fees), underperforming the MSCI World Index, which returned -3.46%, and the MSCI ACWI Index, which returned -3.40%. Please refer to the table below for detailed performance.

Performance (%) 3Q23YTD1 Year3 Years5 Years10 Years Since Inception*
Global Equity Composite (gross)-4.067.3020.997.797.518.929.26
Global Equity Composite (net)-4.137.0520.627.467.168.548.83
MSCI World Index (net)-3.4611.1021.958.087.258.268.82
MSCI ACWI Index (net)-3.4010.0620.806.896.467.557.92
*The inception date for the Global Equity Composite is November 1, 2010. Past performance is not indicative of future results. Aristotle Global Equity Composite returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses. Aristotle Capital Composite returns are preliminary pending final account reconciliation. Please see important disclosures at the end of this document.

Source: FactSet

Past performance is not indicative of future results. Attribution results are based on sector returns which are gross of investment advisory fees. Attribution is based on performance that is gross of investment advisory fees and includes the reinvestment of income.

From a sector perspective, the portfolio’s underperformance relative to the MSCI World Index can be attributed to security selection, while allocation effects had a positive impact. Security selection in Materials, Consumer Discretionary and Information Technology detracted the most from the portfolio’s relative performance. Conversely, security selection in Health Care and Energy and a lack of exposure to Utilities contributed to relative return.

Regionally, both allocation effects and security selection were responsible for the portfolio’s underperformance relative to the MSCI World Index. Security selection in Europe and our exposure in Emerging Markets detracted the most from relative performance, while an overweight in Japan contributed.

Contributors and Detractors for 3Q 2023

Relative ContributorsRelative Detractors
CamecoFMC
AmgenLVMH
TotalEnergiesFANUC
FirstCashNemetschek
OshkoshMicrochip Technology

Japan-based FANUC, the global manufacturer of industrial robots as well as control systems for machine tools, was a primary detractor for the period. During the June quarter, orders for the company’s robots fell 23% year-on-year following ten consecutive quarters of annual increases. This abrupt decline may have been due to inventory adjustments in China and the Americas as many manufacturers became more cautious over capital investments. Looking past the short-term headwinds, we will continue to monitor the company’s progress shifting its revenue mix toward higher-margin service and IoT capabilities, which should improve profitability. This includes its FIELD platform, which offers predictive maintenance, optimization and self-learning that customers can utilize to reduce production downtime and energy costs. Moreover, we believe long-term prospects for the company are underappreciated since FANUC, as the industrial robot market leader, is uniquely positioned to benefit from further penetration of factory automation and robot usage across geographies.

Microchip Technology, the microcontroller (MCU) and analog semiconductor producer, was a primary detractor for the period. Despiteposting record levels of sales, margins and gross profit, management indicated it expects a challenging near-term demand environment due to weakness in China, a slowdown in Europe and early signs of weakness in auto. The company has also accommodated some push-out requests from customers, which will translate into lower sales for the coming months. Despite operating in a cyclical industry, Microchip has been able to generate 15+ years of robust FREE cash flow and margins, while lowering its debt (has paid down $6.8 billion of debt over the last 20 quarters, reducing net leverage to 1.29x) and consistently returning money to shareholders. This, we believe, speaks to management’s proven ability to manage the business through economic cycles, while taking advantage of its broad portfolio to continue gaining share in areas including IoT, 5G infrastructure, autonomous driving and data centers.

Amgen, the biopharmaceutical company, was one of the top contributors for the quarter. The company continues to leverage its innovative platform to strengthen its product portfolio, offset maturing products, such as Epogen and Neulasta, and increase market share. Over the past year, Amgen has reported double-digit volume growth, operating margin expansion to over 40% and record levels of sales for cholesterol drug Repatha, bone-strengthening drug Prolia and cancer drug Blincyto. Additionally, the company remains well positioned to benefit from the continued development and commercialization of biosimilars such as Amgevita, the first biosimilar to Humira, and the successful integration of Otezla to bolster its inflammation segment. Lastly, the FTC agreed to allow Amgen to proceed with its $27.8 billion acquisition of Horizon Therapeutics. We note that this is yet another unsuccessful attempt by the FTC to block an M&A transaction of one of our holdings (see below re: Activision Blizzard). The transaction closed on October 6, 2023 and brings expertise in rare disease therapies (including bulging eye-drug Tepezza), as well as adds to Amgen’s immunology portfolio.

TotalEnergies, one of the world’s largest energy companies, was also a primary contributor for the quarter. The company continues to execute on its strategic plan to reach net-zero emissions by 2050 which, in contrast to many European energy providers, it looks to achieve through expanding ownership of renewable power and low-carbon assets rather than purely divestment. The company expects to more than double its gross renewable generation capacity by 2025 (primarily in solar) and invest over 30% of its total spending in low-carbon businesses through 2030. As such, we believe TotalEnergies is uniquely positioned to benefit from the increase in global demand for clean energy. In recent years, TotalEnergies’ reduction in capex and operating expenses has improved its FREE cash flow generation, now further aided by the favorable energy environment. This has supported its continued ability to return cash to shareholders, one of our catalysts, as demonstrated by the $3.8 billion returned through share buybacks and dividends during the second quarter.

Recent Portfolio Activity

BuysSells
Jazz PharmaceuticalsMagna International

During the quarter, we sold our position in Magna International and invested in a new position, Jazz Pharmaceuticals.

We first invested in Magna International, a Canada-based global auto parts, systems and assembly company, in the first quarter of 2020. The company, in our opinion, has a unique capability of supplying parts for an increasingly electrified and autonomous fleet of vehicles. This includes Magna’s specialty in lightweighting vehicles—a necessity for heavy electric cars—as well as its years of investment in self-driving technologies. In addition, with leading market share positions in many of its core markets and products, we believe Magna remains well positioned to benefit as content-per-vehicle increases and automotive parts and systems become more complex. Though the company continues to meet each of our criteria for investment, we decided to exit our position in Magna to fund our purchase of Jazz Pharmaceuticals, which we view as a more optimal investment.

Jazz Pharmaceuticals plc

Founded in 2003, Jazz Pharmaceuticals is a global biopharmaceutical company headquartered in Ireland. The drugmaker’s portfolio of nine approved products focuses on conditions with limited therapeutic treatments in neuroscience (~75% of 2022 revenue) and oncology (~25%).

Jazz’s drug Xyrem was added to its portfolio in 2005 and was approved for use in patients with narcolepsy. The drug’s strong efficacy propelled it to be the standard of care for this incurable sleep condition and has achieved wide adoption for the treatment of excessive daytime sleepiness and cataplexy (episodes of loss of muscle control).

Xyrem’s patent exclusivity ended in January 2023, and authorized generic versions of the product have entered the market. To prepare for the patent cliff, the company developed Xywav, a lower-sodium version of Xyrem, which is touted for its potentially better heart safety. The drug has received FDA approval for the treatment of narcolepsy and idiopathic hypersomnia and has orphan drug exclusivity through 2027.

Jazz has focused on adding new products to its portfolio through both internal innovation and acquisitions. At the end of 2022, 63% of Jazz’s net product sales were generated from products launched or acquired over the past three years, while 75% of net product sales were generated by a single drug—Xyrem—in 2018. Within oncology, Jazz received recent approvals for Zepzelca (for small cell lung cancer) and Rylaze (for acute lymphoblastic leukemia). In addition, through the acquisition of GW Pharmaceuticals in 2021, Jazz added Epidiolex for the treatment of severe (and rare) forms of epilepsy.

High-Quality Business

Some of the quality characteristics we have identified for Jazz Pharmaceuticals include: 

  • Decades of success developing and marketing novel treatments for rare conditions using biopharmaceuticals;
  • Jazz’s extensive network of sleep doctors provides the company with a competitive edge to promote new therapies;
  • History of strong FREE cash flow generation with a track record of accretive acquisitions; and
  • Pricing power, as the company’s key drugs treat rare diseases where alternative options are limited.

Attractive Valuation

Based on our estimates, shares of the company are attractively valued. We believe continued market share gains for several of the company’s therapies will lead to higher levels of normalized FREE cash flow than are currently appreciated by the market. Though not (yet) incorporated into our estimates, we view the company’s strong neuroscience and oncology pipeline assets as “free options.”

Compelling Catalysts

Catalysts we have identified for Jazz Pharmaceuticals, which we believe will cause its stock price to appreciate over our three- to five-year investment horizon, include:

  • Continued market share gains for Xywav, as this recently released drug has already achieved market-leading adoption in narcolepsy and increased patient usage for idiopathic hypersomnia;
  • Increased penetration of Epidiolex, which has demonstrated strong efficacy and where there are limited therapeutic substitutes for the rare forms of epilepsy it treats; and
  • Further uptake of Zepzelca—a well-established, second-line cancer treatment that is also being studied for potential usage as a first-line treatment.

Conclusion

Rather than attempting to predict short-term market dynamics, at Aristotle Capital, we stay focused on understanding company fundamentals while carefully monitoring the long-term evolution of our portfolio of holdings. Our approach to understanding individual businesses reveals more insightful conclusions than would undue time spent concentrating on ever-changing and often unclear macroeconomic signals. While we strive to remain macro aware, our goal instead is to invest in businesses which are run by what we believe are capable and proven management teams that have the skill to navigate changing factors such as inflation, interest rates and government policy. We also analyze how such factors could alter the fundamentals of a business and whether those impacts are long term in nature.

We aim to find companies with high-quality characteristics that can succeed over full market cycles. It is our belief that a disciplined, research-oriented approach to finding great companies, as well as a consistent, well-executed portfolio management process, is how we can add the most value for our clients.

Disclosures

The opinions expressed herein are those of Aristotle Capital Management, LLC (Aristotle Capital) and are subject to change without notice. Past performance is not a guarantee or indicator of future results. This material is not financial advice or an offer to buy or sell any product. You should not assume that any of the securities transactions, sectors or holdings discussed in this report were or will be profitable, or that recommendations Aristotle Capital makes in the future will be profitable or equal the performance of the securities listed in this report. The portfolio characteristics shown relate to the Aristotle Global Equity strategy. Not every client’s account will have these characteristics. Aristotle Capital reserves the right to modify its current investment strategies and techniques based on changing market dynamics or client needs. There is no assurance that any securities discussed herein will remain in an account’s portfolio at the time you receive this report or that securities sold have not been repurchased. The securities discussed may not represent an account’s entire portfolio and, in the aggregate, may represent only a small percentage of an account’s portfolio holdings. The performance attribution presented is of a representative account from Aristotle Capital’s Global Equity Composite. The representative account is a discretionary client account which was chosen to most closely reflect the investment style of the strategy. The criteria used for representative account selection is based on the account’s period of time under management and its similarity of holdings in relation to the strategy. Recommendations made in the last 12 months are available upon request.

Returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses.

All investments carry a certain degree of risk, including the possible loss of principal. Investments are also subject to political, market, currency and regulatory risks or economic developments. International investments involve special risks that may in particular cause a loss in principal, including currency fluctuation, lower liquidity, different accounting methods and economic and political systems, and higher transaction costs. These risks typically are greater in emerging markets. Securities of small‐ and medium‐sized companies tend to have a shorter history of operations, be more volatile and less liquid. Value stocks can perform differently from the market as a whole and other types of stocks.

The material is provided for informational and/or educational purposes only and is not intended to be and should not be construed as investment, legal or tax advice and/or a legal opinion. Investors should consult their financial and tax adviser before making investments. The opinions referenced are as of the date of publication, may be modified due to changes in the market or economic conditions, and may not necessarily come to pass. Information and data presented has been developed internally and/or obtained from sources believed to be reliable. Aristotle Capital does not guarantee the accuracy, adequacy or completeness of such information.

Aristotle Capital Management, LLC is an independent investment adviser registered under the Investment Advisers Act of 1940, as amended. Registration does not imply a certain level of skill or training. More information about Aristotle Capital, including our investment strategies, fees and objectives, can be found in our Form ADV Part 2, which is available upon request. ACM-2310-34

Performance Disclosures

Composite returns for all periods ended September 30, 2023 are preliminary pending final account reconciliation.

The Aristotle Global Equity Composite has an inception date of November 1, 2010; however, the strategy initially began at Howard Gleicher’s predecessor firm in July 2007. A supplemental performance track record from January 1, 2008 through October 31, 2010 is provided on this page and complements the Global Equity Composite presentation that is located at the end of this presentation. The performance results were achieved while Mr. Gleicher managed the strategy at a prior firm. The returns are those of a publicly available mutual fund from the fund’s inception through Mr. Gleicher’s departure from the firm. During that time, Mr. Gleicher had primary responsibility for managing the fund.

Past performance is not indicative of future results. The information provided should not be considered financial advice or a recommendation to purchase or sell any particular security or product. Performance results for periods greater than one year have been annualized.

Returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses

Index Disclosures

The MSCI World Index is a free float-adjusted market capitalization weighted index that is designed to measure the equity market performance of developed markets. The MSCI World Index consists of the following 23 developed market country indexes: Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Hong Kong, Ireland, Israel, Italy, Japan, Netherlands, New Zealand, Norway, Portugal, Singapore, Spain, Sweden, Switzerland, the United Kingdom and the United States. The MSCI Emerging Markets Index is a free float-adjusted market capitalization-weighted index that is designed to measure equity market performance of emerging markets. The MSCI Emerging Markets Index consists of the following 24 emerging market country indexes: Brazil, Chile, China, Colombia, Czech Republic, Egypt, Greece, Hungary, India, Indonesia, Korea, Kuwait, Malaysia, Mexico, Peru, Philippines, Poland, Qatar, Saudi Arabia, South Africa, Taiwan, Thailand, Turkey and United Arab Emirates. The MSCI ACWI captures large and mid-cap representation across 23 developed markets and 24 emerging markets countries. With approximately 3,000 constituents, the Index covers approximately 85% of the global investable equity opportunity set. The MSCI ACWI Growth Index captures large and mid-cap securities exhibiting overall growth style characteristics across 23 developed markets countries and 24 emerging markets countries. The MSCI ACWI Value Index captures large and mid-cap securities exhibiting overall value style characteristics across 23 developed markets countries and 24 emerging markets countries. The MSCI Europe Index captures large and mid-cap representation across 15 developed markets countries in Europe. With more than 400 constituents, the Index covers approximately 85% of the free float-adjusted market capitalization across the European developed markets equity universe. The MSCI Japan Index is designed to measure the performance of the large and mid-cap segments of the Japanese market. With approximately 250 constituents, the Index covers approximately 85% of the free float-adjusted market capitalization in Japan. The S&P 500® Index is the Standard & Poor’s Composite Index of 500 stocks and is a widely recognized, unmanaged index of common stock prices. The NYSE FAANG+ Index is an equal-dollar-weighted index designed to represent a segment of the Information Technology and Consumer Discretionary sectors consisting of highly traded growth stocks of technology and tech-enabled companies, such as Meta, Apple, Amazon, Netflix and Alphabet’s Google. The Bloomberg Global Aggregate Bond Index is a flagship measure of global investment grade debt from 28 local currency markets. This multi-currency benchmark includes Treasury, government-related, corporate and securitized fixed rate bonds from both developed and emerging markets issuers. The Brent Crude Oil Index is a major trading classification of sweet light crude oil that serves as a major benchmark price for purchases of oil worldwide. The volatility (beta) of the Composite may be greater or less than the benchmarks. It is not possible to invest directly in these indexes.

For more on Global Equity, access the latest resources.

(All MSCI index returns are shown net and in U.S. dollars unless otherwise noted.)

Markets Review

Sources: CAPS CompositeHubTM, Bloomberg
Past performance is not indicative of future results. Aristotle International Equity Composite returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses. Aristotle Capital Composite returns are preliminary pending final account reconciliation. Please see important disclosures at the end of this document.

After three consecutive positive quarters, global equity markets reversed, as the MSCI ACWI Index fell  3.40% during the period. Concurrently, the Bloomberg Global Aggregate Bond Index decreased 3.59%. In terms of style, value stocks outperformed their growth counterparts during the quarter, with the MSCI ACWI Value Index beating the MSCI ACWI Growth Index by 3.13%.

The MSCI EAFE Index declined  4.11% during the third quarter, while the MSCI ACWI ex USA Index dropped  3.77%. Within the MSCI EAFE Index, Europe & Middle East and Asia were the worst-performing regions, while the U.K. declined the least. On a sector basis, nine out of the eleven sectors within the MSCI EAFE Index posted negative returns, with Information Technology, Utilities and Consumer Discretionary as the worst performers. Conversely, Energy and Financials posted positive returns, while Real Estate declined the least.

Although global financial markets experienced less turmoil than they did earlier this year, inflation remains elevated and economic data remains weak. In fact, the IMF forecast global GDP growth to decline to 3.0% in 2023.

China’s recovery remained sluggish amid an ongoing property slump and lackluster consumer spending. Meanwhile, high levels of inflation persisted across many regions of the world, although inflation in the U.S., eurozone and the U.K. eased significantly from levels seen earlier in the year.  Consistent with the progress, the IMF trimmed its global inflation projection to 6.8% from its prior estimate of 7.0% in April but warned inflation could remain high or reaccelerate due to factors such as geopolitics and weather-related events.

By contrast, in Asia, Japanese inflation edged down to 3.2% in August, and the Bank of Japan diverged from its Western counterparts by keeping short-term interest rates steady. China also took an easier approach to its monetary policy, cutting both short- and medium-term lending rates, as the country has struggled to recover following the pandemic. The People’s Bank of China hopes to combat weak consumer spending, falling exports and the country’s real estate crisis. Chinese property developers have come under increased scrutiny, as Evergrande filed for bankruptcy protection in the U.S. while Country Garden warned investors of significant losses.

On the geopolitical front, Ukraine continues to push its counteroffensive in the eastern and southern portions of the country. Western nations have largely remained dedicated to their support of Ukraine, as countries such as the U.S., Canada and the U.K. have all pledged to provide additional aid. In Taiwan, China carried out military exercises in the Taiwan Strait following the Taiwanese vice president’s visit to New York and San Francisco. Despite tense relations between the U.S. and China, the Biden Administration announced $345 million in military aid for Taiwan.

Performance and Attribution Summary

For the third quarter of 2023, Aristotle Capital’s International Equity Composite posted a total return of -4.53% gross of fees (-4.65% net of fees), underperforming the MSCI EAFE Index, which returned -4.11%, and the MSCI ACWI ex USA Index, which returned -3.77%. Please refer to the table below for detailed performance.

Performance (%) 3Q23YTD1 Year3 Years5 Years10 Years Since Inception*
International Equity Composite (gross)-4.537.3622.386.123.414.545.06
International Equity Composite (net)-4.656.9721.805.612.914.034.56
MSCI EAFE Index (net)-4.117.0825.655.753.243.822.16
MSCI ACWI ex USA Index (net)-3.775.3420.393.742.583.351.78
*The inception date for the International Equity Composite is January 1, 2008. Past performance is not indicative of future results. Aristotle International Equity Composite returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses. Aristotle Capital Composite returns are preliminary pending final account reconciliation. Please see important disclosures at the end of this document.

Source: FactSet

Past performance is not indicative of future results. Attribution results are based on sector returns which are gross of investment advisory fees. Attribution is based on performance that is gross of investment advisory fees and includes the reinvestment of income.

From a sector perspective in the third quarter, the portfolio’s underperformance relative to the MSCI EAFE Index can be attributed to both security selection and allocation effects. Security selection in Financials, Industrials and Materials detracted the most from the portfolio’s relative performance. Conversely, security selection in Consumer Discretionary, Energy and Consumer Staples contributed to relative return.

Regionally, security selection was responsible for the portfolio’s underperformance, while allocation effects had a positive impact. Security selection in the U.K. and exposure to Emerging Markets detracted from relative performance, while exposure to Canada and an underweight in Europe & Middle East contributed.

Contributors and Detractors for 3Q 2023

Relative ContributorsRelative Detractors
CamecoFANUC
Pan Pacific InternationalNemetschek
TotalEnergiesDassault Systèmes
Munich ReinsuranceLVMH
DBS GroupDSM-Firmenich

Japan-based FANUC, the global manufacturer of industrial robots as well as control systems for machine tools, was the largest detractor for the period. During the June quarter, orders for the company’s robots fell 23% year-on-year following ten consecutive quarters of annual increases. This abrupt decline may have been due to inventory adjustments in China and the Americas as many manufacturers became more cautious over capital investments. Looking past the short-term headwinds, we will continue to monitor the company’s progress shifting its revenue mix toward higher-margin service and IoT capabilities, which should improve profitability. This includes its FIELD platform, which offers predictive maintenance, optimization and self-learning that customers can utilize to reduce production downtime and energy costs. Moreover, we believe long-term prospects for the company are underappreciated since FANUC, as the industrial robot market leader, is uniquely positioned to benefit from further penetration of factory automation and robot usage across geographies.

LVMH Moët Hennessy Louis Vuitton, the luxury goods company, was a primary detractor for the quarter. After doubling sales over the past three years, LVMH is experiencing a slowdown, with organic growth in the recent semi-annual period of only 17%. Regionally, the luxury retail environment is mixed, as strong performance in Asia contrasts with softer demand in the U.S. and a lack of tourist activity from Chinese nationals. Additionally, the company maintained its long-term investment philosophy with increased advertising and promotional spending, which has pressured margins. Despite these near-term challenges, we believe LVMH’s actions will enhance profitability and expand market share in the long run. This includes the company’s continued shift toward Jewelry, which is now the business’s second-largest segment by profit, market share gains in the Selective Retailing segment due to strong performance from Sephora and DFS (Duty Free Shoppers), the successful integration of brands such as Christian Dior Couture, and ongoing integration of Tiffany & Co., which reopened its New York City flagship store “The Landmark” earlier this year.

Pan Pacific International, the Japanese discount and general merchandise retailer, was a top contributor for the period. After being closed for over two and a half years, Japan’s reopening has led to a sharp recovery in retail traffic. In response, Pan Pacific has implemented an aggressive strategy of increasing the number of cash registers and strengthening staffing to boost sales while also focusing on improving procurement capabilities, expanding its private label strategy and improving its inventory turnover. As a result of these actions, along with favorable weather and a strong holiday season, the company’s sales exceeded pre-pandemic levels, and operating margin eclipsed 5% for the first time in five years. Furthermore, we are encouraged by Pan Pacific’s announcement that it will accelerate the opening of new stores with 25 openings in Japan and 12 stores overseas this year. We believe Pan Pacific is well positioned to continue gaining market share in Japan, further penetrate the overseas market and maintain strong levels of profitability.

TotalEnergies, one of the world’s largest energy companies, was also a primary contributor for the quarter. The company continues to execute on its strategic plan to reach net-zero emissions by 2050 which, in contrast to many European energy providers, it looks to achieve through expanding ownership of renewable power and low-carbon assets rather than purely divestment. The company expects to more than double its gross renewable generation capacity by 2025 (primarily in solar) and invest over 30% of its total spending in low-carbon businesses through 2030. As such, we believe TotalEnergies is uniquely positioned to benefit from the increase in global demand for clean energy. In recent years, TotalEnergies’ reduction in capex and operating expenses has improved its FREE cash flow generation, now further aided by the favorable energy environment. This has supported its continued ability to return cash to shareholders, one of our catalysts, as demonstrated by the $3.8 billion returned through share buybacks and dividends during the second quarter.

Recent Portfolio Activity

BuysSells
NoneNone

Consistent with our long-term horizon and low turnover, there were no new purchases or sales completed during the quarter.

Conclusion

Rather than attempting to predict short-term market dynamics, at Aristotle Capital, we stay focused on understanding company fundamentals while carefully monitoring the long-term evolution of our portfolio of holdings. Our approach to understanding individual businesses reveals more insightful conclusions than would undue time spent concentrating on ever-changing and often unclear macroeconomic signals. While we strive to remain macro aware, our goal instead is to invest in businesses which are run by what we believe are capable and proven management teams that have the skill to navigate changing factors such as inflation, interest rates and government policy. We also analyze how such factors could alter the fundamentals of a business and whether those impacts are long term in nature.

We aim to find companies with high-quality characteristics that can succeed over full market cycles. It is our belief that a disciplined, research-oriented approach to finding great companies, as well as a consistent, well-executed portfolio management process, is how we can add the most value for our clients.

Disclosures

The opinions expressed herein are those of Aristotle Capital Management, LLC (Aristotle Capital) and are subject to change without notice. Past performance is not a guarantee or indicator of future results. This material is not financial advice or an offer to buy or sell any product. You should not assume that any of the securities transactions, sectors or holdings discussed in this report were or will be profitable, or that recommendations Aristotle Capital makes in the future will be profitable or equal the performance of the securities listed in this report. The portfolio characteristics shown relate to the Aristotle International Equity strategy. Not every client’s account will have these characteristics. Aristotle Capital reserves the right to modify its current investment strategies and techniques based on changing market dynamics or client needs. There is no assurance that any securities discussed herein will remain in an account’s portfolio at the time you receive this report or that securities sold have not been repurchased. The securities discussed may not represent an account’s entire portfolio and, in the aggregate, may represent only a small percentage of an account’s portfolio holdings. The performance attribution presented is of a representative account from Aristotle Capital’s International Equity Composite. The representative account is a discretionary client account which was chosen to most closely reflect the investment style of the strategy. The criteria used for representative account selection is based on the account’s period of time under management and its similarity of holdings in relation to the strategy. Recommendations made in the last 12 months are available upon request.

Returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses.

All investments carry a certain degree of risk, including the possible loss of principal. Investments are also subject to political, market, currency and regulatory risks or economic developments. International investments involve special risks that may in particular cause a loss in principal, including currency fluctuation, lower liquidity, different accounting methods and economic and political systems, and higher transaction costs. These risks typically are greater in emerging markets. Securities of small‐ and medium‐sized companies tend to have a shorter history of operations, be more volatile and less liquid. Value stocks can perform differently from the market as a whole and other types of stocks.

The material is provided for informational and/or educational purposes only and is not intended to be and should not be construed as investment, legal or tax advice and/or a legal opinion. Investors should consult their financial and tax adviser before making investments. The opinions referenced are as of the date of publication, may be modified due to changes in the market or economic conditions, and may not necessarily come to pass. Information and data presented has been developed internally and/or obtained from sources believed to be reliable. Aristotle Capital does not guarantee the accuracy, adequacy or completeness of such information.

Aristotle Capital Management, LLC is an independent registered investment adviser under the Advisers Act of 1940, as amended. Registration does not imply a certain level of skill or training. More information about Aristotle Capital, including our investment strategies, fees and objectives, can be found in our Form ADV Part 2, which is available upon request. ACM-2310-25

Performance Disclosures

Composite returns for all periods ended September 30, 2023 are preliminary pending final account reconciliation.

Past performance is not indicative of future results. The information provided should not be considered financial advice or a recommendation to purchase or sell any particular security or product. Performance results for periods greater than one year have been annualized.

Returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses.

Index Disclosures

The MSCI EAFE Index (Europe, Australasia, Far East) is a free float-adjusted market capitalization-weighted index that is designed to measure the equity market performance of developed markets, excluding the United States and Canada. The MSCI EAFE Index consists of the following 21 developed market country indexes: Australia, Austria, Belgium, Denmark, Finland, France, Germany, Hong Kong, Ireland, Israel, Italy, Japan, the Netherlands, New Zealand, Norway, Portugal, Singapore, Spain, Sweden, Switzerland and the United Kingdom. The MSCI ACWI captures large and mid-cap representation across 23 developed market countries and 24 emerging markets countries. With approximately 3,000 constituents, the Index covers approximately 85% of the global investable equity opportunity set. The MSCI ACWI Growth Index captures large and mid-cap securities exhibiting overall growth style characteristics across 23 developed markets countries and 24 emerging markets countries. The MSCI ACWI Value Index captures large and mid-cap securities exhibiting overall value style characteristics across 23 developed markets countries and 24 emerging markets countries. The MSCI ACWI ex USA Index captures large and mid-cap representation across 22 of 23 developed markets countries (excluding the United States) and 24 emerging markets countries. With approximately 2,300 constituents, the Index covers approximately 85% of the global equity opportunity set outside the United States. The MSCI Emerging Markets Index is a free float-adjusted market capitalization-weighted index that is designed to measure the equity market performance of emerging markets. The MSCI Emerging Markets Index consists of the following 24 emerging market country indexes: Brazil, Chile, China, Colombia, Czech Republic, Egypt, Greece, Hungary, India, Indonesia, Korea, Kuwait, Malaysia, Mexico, Peru, Philippines, Poland, Qatar, Saudi Arabia, South Africa, Taiwan, Thailand, Turkey and United Arab Emirates. The S&P 500® Index is the Standard & Poor’s Composite Index of 500 stocks and is a widely recognized, unmanaged index of common stock prices. The Brent Crude Oil Index is a major trading classification of sweet light crude oil that serves as a major benchmark price for purchases of oil worldwide. The MSCI Japan Index is designed to measure the performance of the large and mid-cap segments of the Japanese market. With approximately 250 constituents, the Index covers approximately 85% of the free float-adjusted market capitalization in Japan. The Bloomberg Global Aggregate Bond Index is a flagship measure of global investment grade debt from 28 local currency markets. This multi-currency benchmark includes treasury, government-related, corporate and securitized fixed-rate bonds from both developed and emerging markets issuers. The MSCI United Kingdom Index is designed to measure the performance of the large and mid-cap segments of the U.K. market. With nearly 100 constituents, the Index covers approximately 85% of the free float-adjusted market capitalization in the United Kingdom. The MSCI Europe Index captures large and mid-cap representation across 15 developed markets countries in Europe. With approximately 430 constituents, the Index covers approximately 85% of the free float-adjusted market capitalization across the European developed markets equity universe. These indexes have been selected as the benchmarks and are used for comparison purposes only. The volatility (beta) of the Composite may be greater or less than the respective benchmarks. It is not possible to invest directly in these indexes.

For more on International Equity, access the latest resources.

Markets Review

Sources: CAPS CompositeHubTM, Bloomberg
Past performance is not indicative of future results. Aristotle Value Equity Composite returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses. Aristotle Capital Composite returns are preliminary pending final account reconciliation. Please see important disclosures at the end of this document.

After three consecutive positive quarters, the U.S. equity market pulled back, as the S&P 500 Index declined 3.27% during the quarter. Concurrently, the Bloomberg U.S. Aggregate Bond Index also fell, dropping 3.23% for the quarter. In terms of style, the Russell 1000 Growth Index slightly outperformed its value counterpart by 0.03%.

Declines were broad-based, as ten out of the eleven sectors within the Russell 1000 Value Index finished lower. Consumer Discretionary, Utilities and Real Estate were the worst-performing sectors. Meanwhile, Energy was the only sector in the green, and Financials and Information Technology declined the least.

Economic growth in the U.S. remained steady, as data released during the quarter showed real GDP increased at an annual rate of 2.1%. The increase was driven by higher levels of consumer and government spending, as well as nonresidential fixed investment. The labor market remained tight during the period, with a 3.8% unemployment rate in August, while average hourly earnings for all employees increased by 4.3% year-over-year.

There was an uptick in inflation reported during the quarter, as annualized CPI increased from 3.0% in June to 3.7% in August. In addition, oil hit its highest level of the year, with both WTI and Brent eclipsing $90 a barrel. Given the concerns about rebounding inflation, 10-year and 30-year Treasury yields spiked to their highest marks since 2007 and 2011, finishing the quarter at 4.59% and 4.73%, respectively. However, the broader trend of disinflation continues, as the 3.7% August CPI figure is still less than half the 8.3% increase the Index experienced the year prior.

After raising its benchmark federal funds rate to a range of 5.25% to 5.50% in July, the Federal Reserve (Fed) held interest rates steady in September, citing a solid pace of expanding economic activity, a slightly softer—yet still strong—labor market and tighter credit conditions. The Fed indicated that it would continue to monitor cumulative monetary policy, the lagged effects of policy decisions, and economic and financial developments when determining the extent of additional rate increases.

On the corporate earnings front, S&P 500 companies reported a 4.1% decline in earnings, the third straight quarter that saw a year-over-year decrease. Despite the drop, fewer companies discussed “recession” and “inflation” during the reporting period. Furthermore, aggregate earnings estimates for the third quarter increased by 0.4% (above the 10-year average of -3.4%), the first increase in nearly two years.

Performance and Attribution Summary

For the third quarter of 2023, Aristotle Capital’s Value Equity Composite posted a total return of -2.99% gross of fees (-3.05% net of fees), outperforming the -3.16% return of the Russell 1000 Value Index and the -3.27% return of the S&P 500 Index. Please refer to the table for detailed performance.

Performance (%) 3Q23 YTD 1 Year3 Years5 Years10 Years
Value Equity Composite (gross)-2.995.3816.529.478.8611.25
Value Equity Composite (net)-3.055.1916.239.198.5610.91
Russell 1000 Value Index-3.161.7914.4411.056.228.44
S&P 500 Index-3.2713.0721.6210.159.9111.91
Past performance is not indicative of future results. Aristotle Value Equity Composite returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses. Aristotle Capital Composite returns are preliminary pending final account reconciliation. Please see important disclosures at the end of this document.

Source: FactSet
Past performance is not indicative of future results. Attribution results are based on sector returns which are gross of investment advisory fees. Attribution is based on performance that is gross of investment advisory fees and includes the reinvestment of income.

The portfolio’s outperformance relative to the Russell 1000 Value Index in the third quarter can be attributed to security selection, while allocation effects had a negative impact. Security selection in Health Care, Consumer Discretionary and Communication Services contributed the most to relative performance. Conversely, an underweight in Energy and security selection in Materials and Information Technology detracted. (Relative weights are the result of bottom-up security selection.)

Contributors and Detractors for 3Q 2023

Relative ContributorsRelative Detractors
AmgenXylem
Phillips 66Microchip Technology
BlackstoneCorteva
Mitsubishi UFJ FinancialMartin Marietta Materials
AdobeLennar

Amgen, the biopharmaceutical company, was the top contributor for the quarter. The company continues to leverage its innovative platform to strengthen its product portfolio, offset maturing products, such as Epogen and Neulasta, and increase market share. Over the past year, Amgen has reported double-digit volume growth, operating margin expansion to over 40% and record levels of sales for cholesterol drug Repatha, bone-strengthening drug Prolia and cancer drug Blincyto. Additionally, the company remains well positioned to benefit from the continued development and commercialization of biosimilars such as Amgevita, the first biosimilar to Humira, and the successful integration of Otezla to bolster its inflammation segment. Lastly, the FTC agreed to allow Amgen to proceed with its $27.8 billion acquisition of Horizon Therapeutics. We note that this is yet another unsuccessful attempt by the FTC to block an M&A transaction of one of our holdings (see below re: Activision Blizzard). The transaction closed on October 6, 2023 and brings expertise in rare disease therapies (including bulging eye-drug Tepezza) as well as adds to Amgen’s immunology portfolio.

Phillips 66, a diversified refiner, chemicals and midstream energy company, was a leading contributor for the quarter. While still perceived by many as just a refiner, we continue to be impressed by the company’s ongoing transformation to a more diversified energy business. Consistent with this strategy, Phillips 66 completed the acquisition of DCP Midstream, which expands its NGL (natural gas liquids) business that now spans the entire natural gas value chain, from wellhead to end user. In addition, the company remains on track in converting its San Francisco refinery into one of the world’s largest renewable fuels facilities, with commercial operations set to begin in early 2024. The firm has also made progress on various projects designed to enhance efficiency, increase utilization and bolster capture rates, which can deliver $800 million in cost savings by the end of 2023. With these improvements, as well as further optimization of its midstream and chemicals businesses, we believe Phillips 66 is well positioned to increase its FREE cash flow generation as it continues to become “much more than a refiner.” 

Xylem, the water equipment and services supplier, was the largest detractor for the quarter. After closing the transformational acquisition of Evoqua in May 2023, long-time CEO Patrick Decker announced he would retire at the end of 2023 and COO Matthew Pine will step into the top position. Concurrently, Xylem announced a change in its CFO, with William Grogan joining from IDEX Corporation where he served as CFO since 2017. While C-suite turnover is not desirable, it is inevitable. Moreover, we see the company’s succession planning as well thought out and well executed. Meanwhile, Xylem reported double-digit increases in revenue across all segments and end markets amid strong global demand from public utilities, as well as industrial, commercial and residential clients, that seek solutions to treat, test, transport and preserve water. We believe Xylem’s portfolio of highly differentiated pumps, recognized for their quality and critical uses, as well as the company’s ability to cross‐sell and link other products such as sensors and smart meters, will make it a one‐stop shop for utilities and protect the company from pure price competition. In our opinion, long‐term trends, such as water scarcity and the need to replace aging water infrastructure, create strong underlying demand for Xylem’s products through various parts of the economic cycle. We will evaluate the announced management transitions and will closely monitor the company’s ongoing integration of Evoqua.

Microchip Technology, the microcontroller (MCU) and analog semiconductor producer, was a primary detractor for the period. Despite posting record levels of sales, margins and gross profit, management indicated it expects a challenging near-term demand environment due to weakness in China, a slowdown in Europe and early signs of weakness in auto. The company has also accommodated some push-out requests from customers, which will translate into lower sales for the coming months. Despite operating in a cyclical industry, Microchip has been able to generate 15+ years of robust FREE cash flow and margins, while lowering its debt (has paid down $6.8 billion of debt over the last 20 quarters, reducing net leverage to 1.29x) and consistently returning money to shareholders. This, we believe, speaks to management’s proven ability to manage the business through economic cycles, while taking advantage of its broad portfolio to continue gaining share in areas including IoT, 5G infrastructure, autonomous driving and data centers.

Recent Portfolio Activity

BuysSells
NoneActivision Blizzard

During the quarter, we sold our position in Activision Blizzard.

We first purchased Activision Blizzard, one of the largest video game companies in the world, during the second quarter of 2023. We have long appreciated the critical role Activision Blizzard’s gaming franchises play for PlayStation, Xbox and the broader gaming industry. Moreover, we believe the company is on the path toward increasing its revenue from new products that rely on in-game transactions and advertising, as well as through further leveraging its intellectual property from consoles and PCs into mobile games. At the time of purchase, there was heightened uncertainty regarding whether regulators would approve the pending acquisition of the company by Microsoft, a current Value Equity holding. This, we believe, provided an opportunity for us to own Activision Blizzard at an attractive discount to our estimates of intrinsic value should the company remain independent. Conversely, if the transaction commenced and Activision Blizzard was indeed acquired, we would still benefit through our investment in Microsoft. As such, rather than attempting to predict regulatory approval of the transaction, we instead saw the company as an optimal investment. With the uncertainties regarding regulatory approval nearly disappearing, we decided to exit our investment.

Conclusion

Rather than attempting to predict short-term market dynamics, at Aristotle Capital, we stay focused on understanding company fundamentals while carefully monitoring the long-term evolution of our portfolio of holdings. Our approach to understanding individual businesses reveals more insightful conclusions than would undue time spent concentrating on ever-changing and often unclear macroeconomic signals. While we strive to remain macro aware, our goal instead is to invest in businesses which are run by what we believe are capable and proven management teams that have the skill to navigate changing factors such as inflation, interest rates and government policy. We also analyze how such factors could alter the fundamentals of a business and whether those impacts are long term in nature.

We aim to find companies with high-quality characteristics that can succeed over full market cycles. It is our belief that a disciplined, research-oriented approach to finding great companies, as well as a consistent, well-executed portfolio management process, is how we can add the most value for our clients.

Disclosures

The opinions expressed herein are those of Aristotle Capital Management, LLC (Aristotle Capital) and are subject to change without notice. Past performance is not a guarantee or indicator of future results. This material is not financial advice or an offer to purchase or sell any product. You should not assume that any of the securities transactions, sectors or holdings discussed in this report were or will be profitable, or that recommendations Aristotle Capital makes in the future will be profitable or equal the performance of the securities listed in this report. The portfolio characteristics shown relate to the Aristotle Value Equity strategy. Not every client’s account will have these characteristics. Aristotle Capital reserves the right to modify its current investment strategies and techniques based on changing market dynamics or client needs. There is no assurance that any securities discussed herein will remain in an account’s portfolio at the time you receive this report or that securities sold have not been repurchased. The securities discussed may not represent an account’s entire portfolio and, in the aggregate, may represent only a small percentage of an account’s portfolio holdings. The performance attribution presented is of a representative account from Aristotle Capital’s Value Equity Composite. The representative account is a discretionary client account which was chosen to most closely reflect the investment style of the strategy. The criteria used for representative account selection is based on the account’s period of time under management and its similarity of holdings in relation to the strategy. Recommendations made in the last 12 months are available upon request.

Returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses.

All investments carry a certain degree of risk, including the possible loss of principal. Investments are also subject to political, market, currency and regulatory risks or economic developments. International investments involve special risks that may in particular cause a loss in principal, including currency fluctuation, lower liquidity, different accounting methods and economic and political systems, and higher transaction costs. These risks typically are greater in emerging markets. Securities of small‐ and medium‐sized companies tend to have a shorter history of operations, be more volatile and less liquid. Value stocks can perform differently from the market as a whole and other types of stocks.

The material is provided for informational and/or educational purposes only and is not intended to be and should not be construed as investment, legal or tax advice and/or a legal opinion. Investors should consult their financial and tax adviser before making investments. The opinions referenced are as of the date of publication, may be modified due to changes in the market or economic conditions, and may not necessarily come to pass. Information and data presented has been developed internally and/or obtained from sources believed to be reliable. Aristotle Capital does not guarantee the accuracy, adequacy or completeness of such information.

Aristotle Capital Management, LLC is an independent registered investment adviser under the Advisers Act of 1940, as amended. Registration does not imply a certain level of skill or training. More information about Aristotle Capital, including our investment strategies, fees and objectives, can be found in our ADV Part 2, which is available upon request. ACM-2310-24

Performance Disclosures

Composite returns for all periods ended September 30, 2023 are preliminary pending final account reconciliation.

Past performance is not indicative of future results. The information provided should not be considered financial advice or a recommendation to purchase or sell any particular security or product. Performance results for periods greater than one year have been annualized. The Aristotle Value Equity strategy has an inception date of November 1, 2010; however, the strategy initially began at Mr. Gleicher’s predecessor firm in October 1997. A supplemental performance track record from January 1, 2001 through October 31, 2010 is provided above. The returns are based on two separate accounts and performance results are based on custodian data. During this time, Mr. Gleicher had primary responsibility for managing the two accounts, one account starting in November 2000 and the other December 2000.

Returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses.

Index Disclosures

The Russell 1000 Value® Index measures the performance of the large cap value segment of the U.S. equity universe. It includes those Russell 1000 Index companies with lower price-to-book ratios and lower expected growth values. The S&P 500® Index is the Standard & Poor’s Composite Index of 500 stocks and is a widely recognized, unmanaged index of common stock prices. The Russell 1000® Growth Index measures the performance of the large cap growth segment of the U.S. equity universe. It includes those Russell 1000 companies with higher price-to-book ratios and higher forecasted growth values. The Russell 2000® Index measures the performance of the small cap segment of the U.S. equity universe. The Russell 2000 Index is a subset of the Russell 3000® Index representing approximately 10% of the total market capitalization of that index. It includes approximately 2,000 of the smallest securities based on a combination of their market cap and current index membership. The Dow Jones Industrial Average® is a price-weighted measure of 30 U.S. blue-chip companies. The Index covers all industries except transportation and utilities. The NASDAQ Composite Index measures all NASDAQ domestic and international based common type stocks listed on The NASDAQ Stock Market. The NASDAQ Composite includes over 3,000 companies, more than most other stock market indexes. The Bloomberg U.S. Aggregate Bond Index is an unmanaged index of domestic investment grade bonds, including corporate, government and mortgage-backed securities. The WTI Crude Oil Index is a major trading classification of sweet light crude oil that serves as a major benchmark price for oil consumed in the United States. The Brent Crude Oil Index is a major trading classification of sweet light crude oil that serves as a major benchmark price for purchases of oil worldwide. The 3-Month U.S. Treasury Bill is a short-term debt obligation backed by the U.S. Treasury Department with a maturity of three months. Consumer Price Index is a measure of the average change over time in the prices paid by urban consumers for a market basket of consumer goods and services. The volatility (beta) of the Composite may be greater or less than its respective benchmarks. It is not possible to invest directly in these indexes.

Host: Alex Warren, CFA, CAIA

Guest: Maria Katsileros, CIMC, CSRIC

September 21, 2023

Episode Length: 13:43

In this episode, we speak with Maria Katsileros, Client Portfolio Manager at Aristotle Capital Boston. Maria shares her thoughts on the low valuations of U.S. small cap stocks relative to their own history and larger cap peers, cycles, and tailwinds for the asset class. The conversation also touches on the importance of active management in the space, opportunities in the market, and why small caps deserve a place in portfolios today.

SHOW NOTES
  • Host introduction (0:00-0:19)
  • Episode introduction (0:20-0:45)
  • Introduction of the episode’s guest: Maria Katsileros (0:46-1:31)
  • How have small caps performed in macro environments like the current one? (1:32-2:55)
  • The opportunity in small caps (2:56-4:02)
  • Mean reversion and what will cause a change in fortunes for small caps(4:03-5:30)
  • Other tailwinds supporting small caps (5:31-6:47)
  • Separating the wheat from the chaff in the Russell 2000 Index (6:48-9:26)
  • Where is the investment team seeing opportunities today? (9:27-10:06)
  • Potential trade-offs of timing small cap exposure (10:07-11:27)
  • Why do small caps deserve a place in portfolios today? (11:28-12:40)
  • Conclusion (12:41-13:07)
  • Disclosure (13:10-13:43)
TRANSCRIPT

Alex Warren: Welcome to the Power of Patience, Aristotle’s podcast where we share our views on topics actively explored by our investment teams and across the organization. I’m Alex Warren, product specialist at Aristotle, and I’ll be your host today.

Coming up on today’s episode, we’ll be speaking with Maria Katsileros, Client Portfolio Manager at Aristotle Capital Boston. If you enjoy this podcast, please like and share it on LinkedIn to help spread the word.

Today on the show we’ll discuss the current state of US small-cap stocks, opportunities versus their larger peers, and why small-caps deserve a place in portfolios today.

Without further ado, let’s get started. Maria, thank you so much for joining us today. To lead off the discussion, can you tell me a bit about yourself and your role at Aristotle Capital Boston?

Maria Katsileros: Thank you, Alex. As Alex mentioned, my name is Maria Katsileros and I’m the Client Portfolio Manager for Aristotle Capital Boston, and I’m also a member of the investment team. I’ve been in the industry for 25 years, and prior to joining Aristotle, I was a Senior Vice President and Senior Investment Strategist at a trillion-dollar global asset management firm based out of their North American headquarters in Boston.

In my current role, I serve as the primary day-to-day contact for Aristotle Boston’s clients, providing macroeconomic and asset class-specific insights as well as assisting clients in their servicing needs.

Alex Warren: Wonderful, thank you, Maria. Now let’s dive right in.

It’s been a challenging macro environment for global investors. How have small-caps performed in times like these?

Maria Katsileros: Yes, Alex, it has been a challenging environment. A little over a year ago, we saw inflation peak at 9.1%, and since then it’s rolled over, but remains sticky, and above the Fed’s 2% target. The Fed raised rates by 5% in the past year and a half to tame inflationary pressures, and GDP growth has slowed to below 2% trend.

What’s interesting though is when you look at small-caps historically in similar periods, the asset class has performed quite well. We analyzed all time periods going back to 1950 where inflation started above 3% and was decelerating, meaning it was decreasing in its pace of change, and what we found was that the average return for small-caps during those 18 periods was a little over 20%. And when you compare that to how large-caps performed during those similar time periods, small-caps outperform large-caps by on average of 5%.

Additionally, when looking at historical environments, when inflation was high, but slowing, and economic growth was below trend, so similar to the period where we are today, small-caps were the best performing asset class, posting on average 25% return, almost twice that of the S&P and both corporate and government bonds.

Alex Warren: That makes sense. Now, why do you see an opportunity in US small-caps?

Maria Katsileros: So Alex, when you look at the long-term averages going back to 1928, small-caps have outperformed large-caps by on average by 2%. But we’ve been in a large-cap cycle for the past 14 years, basically since the Great Financial Crisis of 2008, where large-caps have outperformed small-caps by 300 basis points on an average annualized basis.

If you believe as we do that, the markets tend to be mean reverting, the likelihood that the large-cap cycle will end and a small-cap cycle will begin is more likely than not to occur to get us back to those historical norms.

This has happened in the past, so when looking at the Russell 2000 Index, going back to its inception, there have been 81 periods where the five-year trailing return is below the 10.5% average annualized return for the asset class. In all 81 periods, 100% of the time, the five-year return has been higher to get us back to the 10.5% average annualized return, essentially reverting back to the mean.

Alex Warren: Now, Maria, you mentioned mean reversion a moment ago. What do you think will cause a change in fortunes for small-caps?

Maria Katsileros: I’m sure you’ve heard the rhetoric that we’re long in the tooth on this cycle because cycles tend to last eight to 10 years and we’re kind of rubbing up against that if not over that. But the reality is that cycles don’t start and stop based on the number of years. What determines a cycle is based on historical valuations. So it’s purely valuation driven. So when you’re looking at the current valuations, small-caps are cheap not only on an absolute basis but also relative to large-caps and mid-caps. From an absolute basis standpoint, looking at the P/E, so the price to earnings ratio of the Russell 2000 Index, to get as attractively priced as we are today, you have to look back to the 2008 financial crisis.

On a P/E standpoint from a relative basis, when you’re comparing small-caps to large-caps, you have to go back a little over two decades to the 2001 recession that followed the tech bubble bursts of March of 2000 to get as attractive price as we are today. And when you’re comparing them to mid-caps, the relative PEs are the cheapest they’ve been in 25 years. It’s not just on a P/E basis. Whether you’re looking at it from a trailing P/E, forward P/E, price to book, price to sales, enterprise value to free cash flow, so a number of different metrics, small-caps are more attractively priced than large-caps and mid-caps on all of those metrics.

Alex Warren: Those are some interesting stats. Now away from valuation, where do you see other tailwinds?

Maria Katsileros: So there are two macro tailwinds, Alex, that are supporting small-caps and that’s the Russell 2000 Index’s constitution as well as reshoring. From an Index constitution standpoint, large-caps are levered more towards goods, while small-caps are levered more towards services.

As you’ve heard during the past couple of earning seasons, companies are working through an inventory glut as goods spending trailed off after COVID, and instead, customers are spending on experiences, which benefit small-caps.

From a reshoring perspective, we’ve reached a peak of globalization. You’re starting to see reshoring occur to address a lot of the supply chain disruptions many businesses dealt with during the COVID shutdowns. And that’s specifically happening in the semiconductor as well as pharmaceutical industries. So listening to earnings calls, reshoring mentions have skyrocketed and you’re seeing U.S. companies become less dependent on Chinese imports.

Additionally, when you’re looking at manufacturing jobs in the Midwest, they’re three times higher than on the East or West Coast. Reshoring typically leads to CapEx spending, and small-caps have historically had a higher correlation to CapEx spending as compared to large-caps.

Alex Warren: Three times the job openings. Man, that’s a lot of jobs to fill.

Now, let’s take a look at the index. According to Bank of America research, 34% of the Russell 2000 are non-earners. How does the investment team separate the wheat from the chaff?

Maria Katsileros: So you’re spot on, Alex. The Russell 2000 index is comprised of 34% of non-earners. But what’s even more interesting is that the number has increased substantially over the past five years where non-earners were only 20% of the index historically. And in our view, it makes it even more important to not only have a management team that has expertise in the small-cap space, but also to conduct company-specific research.

So for listeners who may not be familiar with Aristotle Capital Boston, we specialize in US small-cap and SMID-cap portfolios. The two co-portfolio managers, Dave Adams and Jack McPherson, have been managing portfolios together for over 20 years, successfully navigating through multiple market environments. And they’re supported by a four member analyst team that has over 25 years of experience.

If I had to describe what we do at the highest level, we’re a high-quality core manager with a slight value tilt, and that value tilt is due to the contrarian front end of our process.

We’re looking for high-quality companies that have sustainable free cash flows, strong balance sheets, wide moats, and by wide moats, I mean strong industry dynamics, and strong management teams that are great capital allocators. But what we don’t want to do is pay up for that future cash flow. So we’re looking to buy those stocks when they’re trading at a discount to our estimate of intrinsic value, which is why we have that slight value tilt.

So to separate the wheat from the chaff, the team starts by narrowing down the universe, blending quantitative flagging tools with qualitative analysis. Those quantitative flagging tools are meant to weed out companies that are selling at excessive valuations or have highly levered balance sheets, allowing the team to truly focus their attention on those companies that either have the characteristics that make them good long-term investments or have the potential to have those characteristics.

From there, the investment process is solely focused on a qualitative assessment of each company where the PMs and the analysts sit down with the management teams, and they truly try to get an understanding of what they see in the opportunity in front of them. They want to understand the strategy, see how they will capitalize on that opportunity, and they want to understand the sensitivities in the business model to assess what the risks are.

We then apply a valuation methodology that looks at the company’s valuation relative to its history, relative to its peer group, and relative to the market overall. When we’re looking to invest in a company, we look to have at least a three to four times upside reward to downside risk before it enters the portfolio.

Alex Warren: Gotcha. Thank you, Maria.

Now let’s dive into a question that I think folks will find very interesting. Where are you seeing opportunities today?

Maria Katsileros: As mentioned earlier, we’re fundamental bottom-up managers, so we’re not looking to make those macro calls from a sector perspective. But what I can tell you is where we’re looking and spending our research time, which tells you where there might be attractive opportunities.

So we’re finding interesting opportunities in the IT, healthcare, and consumer spaces currently. If you had to group the stocks that we currently purchased in the portfolio into a theme, we’ll call it, the two new additions can be tied to automation and the utilization of AI or artificial intelligence to gain business efficiencies.

Alex Warren: Gotcha.

Now, some folks try to tactically overweight or underweight small-cap exposure based on what’s happening in the macro environment. What potential trade-offs are they making with that approach?

Maria Katsileros: Timing the market, Alex, is very hard, and getting both sides of the trade right, meaning timing that entry point and the exit points, is even harder. We typically see investors try to time going overweight the asset class once the Index is bottomed, but trying to determine the exact entry point is difficult, and if you don’t get it right, it can actually be very costly from a return standpoint. So why do I say that?

Our research shows that going back to the inception of the Russell 2000 Index and looking at periods when the market has bottomed, the forward one-year return on average is almost 64%. But missing just the first five trading days after the market bottom, your return decreases by 12% to 52%. Missing the first 10 days shaves off 20% of your return. And if you miss the first month, your return is almost cut in half at just 37%.

So since markets are forward discounting mechanisms, that’s truly a very short window to try to tactically time when to overweight to get the benefit of that strong return that I mentioned.

Alex Warren: Absolutely. That’s a staggering drop-off and frankly, I don’t think I’m smart enough to try to time markets like that.

Now, Maria, this has been a great conversation and we have time for one final question. Looking out over the next five to 10 years, why do you think small-caps deserve a spot in investor portfolios?

Maria Katsileros: If I had to sum it up, the key things to remember are that markets tend to be mean reverting, and the fact that small-caps have underperformed large-caps for such a long time and to the magnitude that they have, based on history, we’re more likely than not to see a small-cap cycle start. But that million-dollar question is when.

Unfortunately, I don’t have a crystal ball, so I can’t tell you whether it’s three months from now, six months from now, or a year from now. But historically, the cycles have started based on valuations. As we’ve discussed, small-cap valuations look attractive on both an absolute as well as a relative basis.

Additionally, small-caps are beneficiaries of the reshoring trend and the CapEx spending that accompanies it, as well as the experiential spending of consumers.

And finally, one thing that we haven’t touched upon is that the asset class itself is the first asset class to recover going into the early part of the economic cycle. So whether the Fed can pull off a soft landing or we go into a mild recession, once we enter the early part of the economic cycle, small-caps are going to lead the way out.

Alex Warren: That makes sense. Maria, thank you so much for your time today. That brings us to the end of this episode. We hope you’ve enjoyed it and learned more about Aristotle. Thank you for listening to the Power of Patience.

To learn more about Aristotle, please visit www.aristotlecap.com or follow the link in the show notes. If you enjoyed the show, please rate and review us on Spotify and Apple Podcast. On behalf of Aristotle, this is Alex Warren, and thank you for listening.

The opinions expressed herein are those of Aristotle Capital Boston and are subject to change without notice. This material is not financial advice or an offer to purchase or sell any product. Aristotle Boston reserves the right to modify its current investment strategies and techniques based on changing market dynamics or client needs.

Aristotle Capital Boston, LLC, is an independent investment advisor, registered under the Investment Advisors Act of 1940 as amended. Please see additional disclosures within the show notes.

DISCLOSURE

For additional disclosures please refer to www.aristotlecap.com

The last decade has been a story of large cap outperformance. Since June 2003, the Russell 3000 Index has grown four-fold, largely on the strength of the large cap companies in the Russell 1000 Index. The market capitalization of the next two thousand companies in the Index has fallen from a high of 9.5% to a twenty-year low of 5.5% in the spring of 2023. You can make the argument that large cap stocks are expensive or that U.S. small caps are cheap. We will focus on the latter, with small cap valuations low versus their larger peers as well as against their own history. Starting at a low in valuations and weaving in multiple tailwinds that could support small cap performance in the years ahead, we believe now may be the time for investors to take a second look.

To read the full thought piece, please use the link below. 

Key Takeaways:

  • Applying a “sustainable lens” to investing in Aristotle Atlantic’s secular themes can reveal positive sustainability attributes that can enhance the long-term potential of an investment.
  • Secular themes represent significant long-term shifts in spending patterns across industries and geographies, with many presenting unique opportunities that we believe can be aligned with the UN SDGs.
  • Cloud computing is a revolutionary technology that can provide cost reduction, efficiency improvement, cybersecurity enhancement and environmental sustainability.
  • Personalized health utilizes genetic data to optimize therapeutic outcomes, reduce waste and improve access to healthcare.
  • Secular themes that we identify as having positive sustainable attributes can enhance an investment view while aligning investment strategies with positive societal and environmental impacts.

To read the full thought piece, please use the link below.